$SWK
STANLEY BLACK & DECKER, INC.

2021 Q1 Form 10-K Financial Statement

#000009355621000008 Filed on February 18, 2021

View on sec.gov

Income Statement

Concept 2021 Q1 2021 2019 Q4
Revenue $4.408B $13.06B $3.714B
YoY Change 59.66% -10.16% 2.19%
Cost Of Revenue $2.840B $8.652B $2.536B
YoY Change 34.82% -8.88% 4.66%
Gross Profit $1.568B $4.405B $1.161B
YoY Change 77.61% -12.57% 0.06%
Gross Profit Margin 35.57% 33.74% 31.25%
Selling, General & Admin $839.2M $2.600B $671.7M
YoY Change 13.74% -3.83% -7.91%
% of Gross Profit 53.53% 59.01% 57.88%
Research & Development $200.0M
YoY Change -5.21%
% of Gross Profit 4.54%
Depreciation & Amortization $147.0M $332.6M $139.8M
YoY Change 58.41% -42.47% 11.39%
% of Gross Profit 9.38% 7.55% 12.05%
Operating Expenses $897.9M $2.800B $720.4M
YoY Change 21.7% -11.63% -7.72%
Operating Profit $669.9M $2.176B $440.2M
YoY Change 107.08% 16.3% 16.09%
Interest Expense -$50.00M $222.6M -$57.40M
YoY Change -183.75% -208.59% 22.13%
% of Operating Profit -7.46% 10.23% -13.04%
Other Income/Expense, Net
YoY Change
Pretax Income $540.1M $174.7M $236.8M
YoY Change 269.43% -86.21% 38.48%
Income Tax $67.40M $43.00M $25.30M
% Of Pretax Income 12.48% 24.61% 10.68%
Net Earnings $467.3M $1.234B $199.1M
YoY Change 250.83% 1.97% -286.42%
Net Earnings / Revenue 10.6% 9.45% 5.36%
Basic Earnings Per Share $7.85 $1.34
Diluted Earnings Per Share $2.935M $7.46 $1.32
COMMON SHARES
Basic Shares Outstanding 160.9M shares 154.2M shares 152.0M shares
Diluted Shares Outstanding 162.4M shares

Balance Sheet

Concept 2021 Q1 2021 2019 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.381B $1.381B $298.0M
YoY Change 39.92% 0.0% 3.11%
Cash & Equivalents $1.242B $1.381B $297.7M
Short-Term Investments
Other Short-Term Assets $34.60M $406.0M $53.90M
YoY Change -92.97% 0.0% -8.49%
Inventory $2.639B $2.737B $2.255B
Prepaid Expenses $326.8M $395.4M
Receivables $1.205B $1.205B $1.455B
Other Receivables $307.0M $307.0M $0.00
Total Short-Term Assets $6.036B $6.036B $4.457B
YoY Change 6.03% 0.0% -2.47%
LONG-TERM ASSETS
Property, Plant & Equipment $1.973B $2.577B $1.960B
YoY Change -3.12% 0.0% 2.31%
Goodwill $8.087B $7.381B
YoY Change -16.87% -17.6%
Intangibles $4.055B $3.622B
YoY Change -2.28% 3.95%
Long-Term Investments
YoY Change
Other Assets $1.114B $720.0M $1.321B
YoY Change -14.16% 0.0% 173.9%
Total Long-Term Assets $17.53B $17.53B $16.14B
YoY Change 1.85% 0.0% 8.77%
TOTAL ASSETS
Total Short-Term Assets $6.036B $6.036B $4.457B
Total Long-Term Assets $17.53B $17.53B $16.14B
Total Assets $23.57B $23.57B $20.60B
YoY Change 2.89% 0.0% 6.12%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.320B $2.446B $2.088B
YoY Change 14.33% 0.0% -6.51%
Accrued Expenses $1.846B $1.467B $1.978B
YoY Change 10.95% 0.0% 42.29%
Deferred Revenue $39.40M
YoY Change
Short-Term Debt $1.500M $2.000M $337.3M
YoY Change -99.91% 0.0% -10.32%
Long-Term Debt Due $0.00 $0.00 $3.100M
YoY Change -100.0% -99.68%
Total Short-Term Liabilities $4.558B $4.558B $4.406B
YoY Change -15.12% 0.0% 10.1%
LONG-TERM LIABILITIES
Long-Term Debt $4.245B $4.245B $3.176B
YoY Change -8.95% 0.0% -16.84%
Other Long-Term Liabilities $2.403B $3.128B $2.532B
YoY Change -7.52% 0.0% 3.5%
Total Long-Term Liabilities $6.649B $7.373B $5.708B
YoY Change -8.44% 0.0% -8.9%
TOTAL LIABILITIES
Total Short-Term Liabilities $4.558B $4.558B $4.406B
Total Long-Term Liabilities $6.649B $7.373B $5.708B
Total Liabilities $11.21B $12.51B $10.11B
YoY Change -11.28% 0.0% -1.5%
SHAREHOLDERS EQUITY
Retained Earnings $7.542B $6.773B
YoY Change 10.97% 8.9%
Common Stock $5.410B $4.935B
YoY Change 9.54% -2.53%
Preferred Stock
YoY Change
Treasury Stock (at cost) $1.549B $2.185B
YoY Change -27.56% -7.86%
Treasury Stock Shares 16.15M shares 23.40M shares
Shareholders Equity $11.06B $11.06B $9.136B
YoY Change
Total Liabilities & Shareholders Equity $23.57B $23.57B $20.60B
YoY Change 2.89% 0.0% 6.12%

Cashflow Statement

Concept 2021 Q1 2021 2019 Q4
OPERATING ACTIVITIES
Net Income $467.3M $1.234B $199.1M
YoY Change 250.83% 1.97% -286.42%
Depreciation, Depletion And Amortization $147.0M $332.6M $139.8M
YoY Change 58.41% -42.47% 11.39%
Cash From Operating Activities $1.422B $2.022B $1.243B
YoY Change -450.91% 0.0% 1.84%
INVESTING ACTIVITIES
Capital Expenditures -$138.6M $348.1M -$141.2M
YoY Change -267.19% -200.0% -14.27%
Acquisitions $1.324B
YoY Change
Other Investing Activities $45.80M $5.900M $72.50M
YoY Change -1337.84% -100.48% 204.62%
Cash From Investing Activities -$92.80M -$1.577B -$68.70M
YoY Change -93.19% 0.0% -51.24%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net -$120.8M
YoY Change -113.87%
Debt Paid & Issued, Net $1.154B
YoY Change
Cash From Financing Activities -657.6M $615.9M -1.203B
YoY Change -126.57% 0.0% 5.8%
NET CHANGE
Cash From Operating Activities 1.422B $2.022B 1.243B
Cash From Investing Activities -92.80M -$1.577B -68.70M
Cash From Financing Activities -657.6M $615.9M -1.203B
Net Change In Cash 671.5M $1.084B -28.80M
YoY Change -1.78% 2.15% -49.91%
FREE CASH FLOW
Cash From Operating Activities $1.422B $2.022B $1.243B
Capital Expenditures -$138.6M $348.1M -$141.2M
Free Cash Flow $1.560B $1.674B $1.385B
YoY Change -419.71% -29.37% -0.07%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021 dei Entity Central Index Key
EntityCentralIndexKey
0000093556
CY2021 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--01-02
CY2021 dei Document Type
DocumentType
10-K
CY2021 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
CY2021 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2021 dei Amendment Flag
AmendmentFlag
false
CY2021 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
2.78
CY2019 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
2.70
CY2018 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
2.58
CY2021 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
228541 shares
CY2019 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
187377 shares
CY2018 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
3677435 shares
CY2021 us-gaap Fiscal Period Duration
FiscalPeriodDuration
P364D
CY2019 us-gaap Fiscal Period Duration
FiscalPeriodDuration
P364D
CY2018 us-gaap Fiscal Period Duration
FiscalPeriodDuration
P364D
CY2021Q1 us-gaap Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List
OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
us-gaap:OtherAssets
CY2021Q1 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent
CY2019Q4 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent
CY2021Q1 us-gaap Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List
OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
us-gaap:OtherLiabilitiesNoncurrent
CY2021 dei Document Type
DocumentType
10-K
CY2021 dei Document Annual Report
DocumentAnnualReport
true
CY2021 dei Document Period End Date
DocumentPeriodEndDate
2021-01-02
CY2021 dei Document Transition Report
DocumentTransitionReport
false
CY2021 dei Entity File Number
EntityFileNumber
001-05224
CY2021 dei Entity Registrant Name
EntityRegistrantName
STANLEY BLACK & DECKER, INC.
CY2021 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
CT
CY2021 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
06-0548860
CY2021 dei Entity Address Address Line1
EntityAddressAddressLine1
1000 STANLEY DRIVE
CY2021 dei Entity Address City Or Town
EntityAddressCityOrTown
NEW BRITAIN
CY2021 dei Entity Address State Or Province
EntityAddressStateOrProvince
CT
CY2021 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
06053
CY2021 dei City Area Code
CityAreaCode
860
CY2021 dei Local Phone Number
LocalPhoneNumber
225-5111
CY2021 dei Security12b Title
Security12bTitle
Common Stock
CY2021 dei Trading Symbol
TradingSymbol
SWK
CY2021 dei Security Exchange Name
SecurityExchangeName
NYSE
CY2021 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
Yes
CY2021 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2021 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2021 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2021 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2021 dei Entity Small Business
EntitySmallBusiness
false
CY2021 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2021 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
true
CY2021 dei Entity Shell Company
EntityShellCompany
false
CY2020Q2 dei Entity Public Float
EntityPublicFloat
21800000000 USD
CY2021Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
160893004 shares
CY2021 us-gaap Revenues
Revenues
14534600000 USD
CY2019 us-gaap Revenues
Revenues
14442200000 USD
CY2018 us-gaap Revenues
Revenues
13982400000 USD
CY2021 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
9566700000 USD
CY2019 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
9636700000 USD
CY2018 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
9131300000 USD
CY2021 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3048500000 USD
CY2019 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3008000000.0 USD
CY2018 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3143700000 USD
CY2021 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
41100000 USD
CY2019 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
33000000.0 USD
CY2018 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
28000000.0 USD
CY2021 us-gaap Other Noninterest Expense
OtherNoninterestExpense
262800000 USD
CY2019 us-gaap Other Noninterest Expense
OtherNoninterestExpense
249100000 USD
CY2018 us-gaap Other Noninterest Expense
OtherNoninterestExpense
287000000.0 USD
CY2021 us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
-13500000 USD
CY2019 us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
17000000.0 USD
CY2018 us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
-800000 USD
CY2021 us-gaap Restructuring Settlement And Impairment Provisions
RestructuringSettlementAndImpairmentProvisions
83000000.0 USD
CY2019 us-gaap Restructuring Settlement And Impairment Provisions
RestructuringSettlementAndImpairmentProvisions
154100000 USD
CY2018 us-gaap Restructuring Settlement And Impairment Provisions
RestructuringSettlementAndImpairmentProvisions
160300000 USD
CY2021 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-46900000 USD
CY2019 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-17900000 USD
CY2018 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
CY2021 us-gaap Investment Income Interest
InvestmentIncomeInterest
18000000.0 USD
CY2019 us-gaap Investment Income Interest
InvestmentIncomeInterest
53900000 USD
CY2018 us-gaap Investment Income Interest
InvestmentIncomeInterest
68700000 USD
CY2021 us-gaap Interest Expense
InterestExpense
223100000 USD
CY2019 us-gaap Interest Expense
InterestExpense
284300000 USD
CY2018 us-gaap Interest Expense
InterestExpense
277900000 USD
CY2021 us-gaap Costs And Expenses
CostsAndExpenses
13267600000 USD
CY2019 us-gaap Costs And Expenses
CostsAndExpenses
13312200000 USD
CY2018 us-gaap Costs And Expenses
CostsAndExpenses
12960300000 USD
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
1267000000.0 USD
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
1130000000.0 USD
CY2018 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
1022100000 USD
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
41400000 USD
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
160800000 USD
CY2018 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
416300000 USD
CY2021 swk Income Lossfrom Continuing Operations Netof Taxbefore Equity Method Investmentsand Noncontrolling Interest
IncomeLossfromContinuingOperationsNetofTaxbeforeEquityMethodInvestmentsandNoncontrollingInterest
1225600000 USD
CY2019 swk Income Lossfrom Continuing Operations Netof Taxbefore Equity Method Investmentsand Noncontrolling Interest
IncomeLossfromContinuingOperationsNetofTaxbeforeEquityMethodInvestmentsandNoncontrollingInterest
969200000 USD
CY2018 swk Income Lossfrom Continuing Operations Netof Taxbefore Equity Method Investmentsand Noncontrolling Interest
IncomeLossfromContinuingOperationsNetofTaxbeforeEquityMethodInvestmentsandNoncontrollingInterest
605800000 USD
CY2021 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
9100000 USD
CY2019 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-11200000 USD
CY2018 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
0 USD
CY2021 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
1234700000 USD
CY2019 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
958000000.0 USD
CY2018 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
605800000 USD
CY2021 us-gaap Income Loss From Continuing Operations Attributable To Noncontrolling Entity
IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity
900000 USD
CY2019 us-gaap Income Loss From Continuing Operations Attributable To Noncontrolling Entity
IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity
2200000 USD
CY2018 us-gaap Income Loss From Continuing Operations Attributable To Noncontrolling Entity
IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity
600000 USD
CY2021 us-gaap Net Income Loss
NetIncomeLoss
1233800000 USD
CY2019 us-gaap Net Income Loss
NetIncomeLoss
955800000 USD
CY2018 us-gaap Net Income Loss
NetIncomeLoss
605200000 USD
CY2021 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
23400000 USD
CY2019 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
0 USD
CY2018 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
0 USD
CY2021 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
1210400000 USD
CY2019 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
955800000 USD
CY2018 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
605200000 USD
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
7.85
CY2019 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
6.44
CY2018 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
4.06
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
7.77
CY2019 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
6.35
CY2018 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
3.99
CY2021 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
1210400000 USD
CY2019 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
955800000 USD
CY2018 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
605200000 USD
CY2021 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
281900000 USD
CY2019 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-36000000.0 USD
CY2018 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-373000000.0 USD
CY2021 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax Parent
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent
-48800000 USD
CY2019 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax Parent
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent
-27400000 USD
CY2018 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax Parent
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent
85800000 USD
CY2021 us-gaap Other Comprehensive Income Loss Derivative Excluded Component Increase Decrease After Adjustments And Tax Parent
OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsAndTaxParent
-24500000 USD
CY2019 us-gaap Other Comprehensive Income Loss Derivative Excluded Component Increase Decrease After Adjustments And Tax Parent
OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsAndTaxParent
34000000.0 USD
CY2019 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-70300000 USD
CY2018 us-gaap Translation Adjustment For Net Investment Hedge Increase Decrease Net Of Tax
TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax
59900000 USD
CY2021 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
37700000 USD
CY2019 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
40900000 USD
CY2018 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
-2100000 USD
CY2021 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
170900000 USD
CY2018 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-225200000 USD
CY2021 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1381300000 USD
CY2019 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
885500000 USD
CY2018 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
380000000.0 USD
CY2021Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1381000000.0 USD
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
297700000 USD
CY2021Q1 us-gaap Accounts Notes And Loans Receivable Net Current
AccountsNotesAndLoansReceivableNetCurrent
1512200000 USD
CY2019Q4 us-gaap Accounts Notes And Loans Receivable Net Current
AccountsNotesAndLoansReceivableNetCurrent
1454600000 USD
CY2021Q1 us-gaap Inventory Net
InventoryNet
2737400000 USD
CY2019Q4 us-gaap Inventory Net
InventoryNet
2255000000.0 USD
CY2021Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
370700000 USD
CY2019Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
395400000 USD
CY2021Q1 us-gaap Other Assets Current
OtherAssetsCurrent
34700000 USD
CY2019Q4 us-gaap Other Assets Current
OtherAssetsCurrent
53900000 USD
CY2021Q1 us-gaap Assets Current
AssetsCurrent
6036000000.0 USD
CY2019Q4 us-gaap Assets Current
AssetsCurrent
4456600000 USD
CY2021Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2053800000 USD
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1959500000 USD
CY2021Q1 us-gaap Goodwill
Goodwill
10038100000 USD
CY2019Q4 us-gaap Goodwill
Goodwill
9237500000 USD
CY2021Q1 swk Customer Relationship Intangible Assets Net
CustomerRelationshipIntangibleAssetsNet
1735100000 USD
CY2019Q4 swk Customer Relationship Intangible Assets Net
CustomerRelationshipIntangibleAssetsNet
1317300000 USD
CY2021Q1 swk Trade Names Net
TradeNamesNet
2277300000 USD
CY2019Q4 swk Trade Names Net
TradeNamesNet
2253600000 USD
CY2021Q1 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
43000000.0 USD
CY2019Q4 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
51100000 USD
CY2021Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1383000000.0 USD
CY2019Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1321000000.0 USD
CY2021Q1 us-gaap Assets
Assets
23566300000 USD
CY2019Q4 us-gaap Assets
Assets
20596600000 USD
CY2021Q1 us-gaap Short Term Borrowings
ShortTermBorrowings
1500000 USD
CY2019Q4 us-gaap Short Term Borrowings
ShortTermBorrowings
337300000 USD
CY2021Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
0 USD
CY2019Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
3100000 USD
CY2021Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
2446400000 USD
CY2019Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2087800000 USD
CY2021Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2110400000 USD
CY2019Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1977500000 USD
CY2021Q1 us-gaap Liabilities Current
LiabilitiesCurrent
4558300000 USD
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
4405700000 USD
CY2021Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
4245400000 USD
CY2019Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
3176400000 USD
CY2021Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
568000000.0 USD
CY2019Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
731200000 USD
CY2021Q1 us-gaap Pension And Other Postretirement Defined Benefit Plans Liabilities Noncurrent
PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent
642600000 USD
CY2019Q4 us-gaap Pension And Other Postretirement Defined Benefit Plans Liabilities Noncurrent
PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent
609400000 USD
CY2021Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2485600000 USD
CY2019Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2531700000 USD
CY2021Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2019Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2019Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2021Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2019Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
1500000 shares
CY2021Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
1500000 shares
CY2019Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
1500000 shares
CY2021Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
1500000 shares
CY2021Q1 us-gaap Preferred Stock Value
PreferredStockValue
1500000000.0 USD
CY2019Q4 us-gaap Preferred Stock Value
PreferredStockValue
1500000000.0 USD
CY2021Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
2.50
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
2.50
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2021Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
176902738 shares
CY2021Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
176902738 shares
CY2021Q1 us-gaap Common Stock Value
CommonStockValue
442300000 USD
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
442300000 USD
CY2021Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
7547600000 USD
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
6772800000 USD
CY2021Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
4832700000 USD
CY2019Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
4492900000 USD
CY2021Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1713700000 USD
CY2019Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1884600000 USD
CY2021Q1 us-gaap Unearned Esop Shares
UnearnedESOPShares
0 USD
CY2019Q4 us-gaap Unearned Esop Shares
UnearnedESOPShares
2300000 USD
CY2021Q1 swk Stockholders Equity Subtotal
StockholdersEquitySubtotal
12608900000 USD
CY2019Q4 swk Stockholders Equity Subtotal
StockholdersEquitySubtotal
11321100000 USD
CY2021Q1 us-gaap Treasury Stock Shares
TreasuryStockShares
16150476 shares
CY2019Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
23396329 shares
CY2021Q1 us-gaap Treasury Stock Value
TreasuryStockValue
1549300000 USD
CY2019Q4 us-gaap Treasury Stock Value
TreasuryStockValue
2184800000 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
11059600000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
9136300000 USD
CY2021Q1 us-gaap Minority Interest
MinorityInterest
6800000 USD
CY2019Q4 us-gaap Minority Interest
MinorityInterest
5900000 USD
CY2021Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
11066400000 USD
CY2019Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
9142200000 USD
CY2021Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
23566300000 USD
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
20596600000 USD
CY2018 us-gaap Depreciation And Amortization
DepreciationAndAmortization
331200000 USD
CY2021 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
201600000 USD
CY2021 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
1234700000 USD
CY2019 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
958000000.0 USD
CY2018 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
605800000 USD
CY2021 us-gaap Depreciation And Amortization
DepreciationAndAmortization
376500000 USD
CY2019 us-gaap Depreciation And Amortization
DepreciationAndAmortization
372800000 USD
CY2019 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
187400000 USD
CY2018 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
175300000 USD
CY2021 swk Inventorystepupamortization
Inventorystepupamortization
29000000.0 USD
CY2019 swk Inventorystepupamortization
Inventorystepupamortization
7400000 USD
CY2018 swk Inventorystepupamortization
Inventorystepupamortization
9600000 USD
CY2021 us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
-13500000 USD
CY2019 us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
17000000.0 USD
CY2018 us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
-800000 USD
CY2021 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-46900000 USD
CY2019 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-17900000 USD
CY2018 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
109100000 USD
CY2019 us-gaap Share Based Compensation
ShareBasedCompensation
88800000 USD
CY2018 us-gaap Share Based Compensation
ShareBasedCompensation
76500000 USD
CY2021 swk Provision For Doubtful Accounts Including Divestiture
ProvisionForDoubtfulAccountsIncludingDivestiture
41100000 USD
CY2019 swk Provision For Doubtful Accounts Including Divestiture
ProvisionForDoubtfulAccountsIncludingDivestiture
33000000.0 USD
CY2018 swk Provision For Doubtful Accounts Including Divestiture
ProvisionForDoubtfulAccountsIncludingDivestiture
28000000.0 USD
CY2021 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
9100000 USD
CY2019 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-11200000 USD
CY2018 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
0 USD
CY2021 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-241700000 USD
CY2019 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-17900000 USD
CY2018 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
191100000 USD
CY2021 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-44700000 USD
CY2019 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
13800000 USD
CY2018 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-10100000 USD
CY2021 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
39600000 USD
CY2019 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-137800000 USD
CY2018 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
48800000 USD
CY2021 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
401500000 USD
CY2019 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-137700000 USD
CY2018 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
401600000 USD
CY2021 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
310400000 USD
CY2019 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-169100000 USD
CY2018 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
211000000.0 USD
CY2021 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-300000 USD
CY2019 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
8500000 USD
CY2018 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
1500000 USD
CY2021 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
100200000 USD
CY2019 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
183600000 USD
CY2018 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
4400000 USD
CY2021 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
14000000.0 USD
CY2019 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
37300000 USD
CY2018 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-28900000 USD
CY2021 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
381700000 USD
CY2019 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
123600000 USD
CY2018 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
70100000 USD
CY2021 us-gaap Increase Decrease In Pension And Postretirement Obligations
IncreaseDecreaseInPensionAndPostretirementObligations
-40200000 USD
CY2019 us-gaap Increase Decrease In Pension And Postretirement Obligations
IncreaseDecreaseInPensionAndPostretirementObligations
-47600000 USD
CY2018 us-gaap Increase Decrease In Pension And Postretirement Obligations
IncreaseDecreaseInPensionAndPostretirementObligations
-44700000 USD
CY2021 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
79500000 USD
CY2019 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-92100000 USD
CY2018 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
20500000 USD
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
2022100000 USD
CY2019 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1505700000 USD
CY2018 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1260900000 USD
CY2021 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
348100000 USD
CY2019 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
424700000 USD
CY2018 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
492100000 USD
CY2021 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
19900000 USD
CY2019 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
100100000 USD
CY2018 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
45200000 USD
CY2021 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
1324400000 USD
CY2019 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
685400000 USD
CY2018 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
524600000 USD
CY2021 us-gaap Proceeds From Divestiture Of Businesses Net Of Cash Divested
ProceedsFromDivestitureOfBusinessesNetOfCashDivested
59100000 USD
CY2019 us-gaap Proceeds From Divestiture Of Businesses Net Of Cash Divested
ProceedsFromDivestitureOfBusinessesNetOfCashDivested
76600000 USD
CY2018 us-gaap Proceeds From Divestiture Of Businesses Net Of Cash Divested
ProceedsFromDivestitureOfBusinessesNetOfCashDivested
-3000000.0 USD
CY2021 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
18700000 USD
CY2019 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
260600000 USD
CY2018 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
21700000 USD
CY2021 us-gaap Payments For Proceeds From Derivative Instrument Investing Activities
PaymentsForProceedsFromDerivativeInstrumentInvestingActivities
-41000000.0 USD
CY2019 us-gaap Payments For Proceeds From Derivative Instrument Investing Activities
PaymentsForProceedsFromDerivativeInstrumentInvestingActivities
-8000000.0 USD
CY2018 us-gaap Payments For Proceeds From Derivative Instrument Investing Activities
PaymentsForProceedsFromDerivativeInstrumentInvestingActivities
-25700000 USD
CY2021 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
5900000 USD
CY2019 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
22600000 USD
CY2018 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
18600000 USD
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1577100000 USD
CY2019 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1208600000 USD
CY2018 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-989100000 USD
CY2021 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
1154300000 USD
CY2019 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
1150000000.0 USD
CY2018 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
977500000 USD
CY2021 us-gaap Proceeds From Issuance Of Unsecured Debt
ProceedsFromIssuanceOfUnsecuredDebt
2222500000 USD
CY2019 us-gaap Proceeds From Issuance Of Unsecured Debt
ProceedsFromIssuanceOfUnsecuredDebt
496200000 USD
CY2018 us-gaap Proceeds From Issuance Of Unsecured Debt
ProceedsFromIssuanceOfUnsecuredDebt
990000000.0 USD
CY2021 us-gaap Proceeds From Repayments Of Short Term Debt
ProceedsFromRepaymentsOfShortTermDebt
-342600000 USD
CY2019 us-gaap Proceeds From Repayments Of Short Term Debt
ProceedsFromRepaymentsOfShortTermDebt
-18100000 USD
CY2018 us-gaap Proceeds From Repayments Of Short Term Debt
ProceedsFromRepaymentsOfShortTermDebt
433200000 USD
CY2021 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
59800000 USD
CY2019 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
40300000 USD
CY2018 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
40300000 USD
CY2021 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
26200000 USD
CY2019 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
27500000 USD
CY2018 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
527100000 USD
CY2021 us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
0 USD
CY2019 us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
735000000.0 USD
CY2018 us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
0 USD
CY2021 us-gaap Payments For Repurchase Of Other Equity
PaymentsForRepurchaseOfOtherEquity
0 USD
CY2019 us-gaap Payments For Repurchase Of Other Equity
PaymentsForRepurchaseOfOtherEquity
19200000 USD
CY2018 us-gaap Payments For Repurchase Of Other Equity
PaymentsForRepurchaseOfOtherEquity
57300000 USD
CY2021 us-gaap Payments Of Debt Extinguishment Costs
PaymentsOfDebtExtinguishmentCosts
48700000 USD
CY2019 us-gaap Payments Of Debt Extinguishment Costs
PaymentsOfDebtExtinguishmentCosts
0 USD
CY2018 us-gaap Payments Of Debt Extinguishment Costs
PaymentsOfDebtExtinguishmentCosts
0 USD
CY2021 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
897000000.0 USD
CY2019 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
146000000.0 USD
CY2019 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
0 USD
CY2018 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
0 USD
CY2021 us-gaap Interest Rate Cash Flow Hedge Gain Loss Reclassified To Earnings Net
InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet
20500000 USD
CY2019 us-gaap Interest Rate Cash Flow Hedge Gain Loss Reclassified To Earnings Net
InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet
1000000.0 USD
CY2018 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
38500000 USD
CY2021 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-250000000.0 USD
CY2018 us-gaap Interest Rate Cash Flow Hedge Gain Loss Reclassified To Earnings Net
InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet
22700000 USD
CY2021 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
431800000 USD
CY2019 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
402000000.0 USD
CY2018 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
384900000 USD
CY2021 us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
18800000 USD
CY2019 us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
0 USD
CY2018 us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
0 USD
CY2021 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-10600000 USD
CY2019 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-11600000 USD
CY2018 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-13500000 USD
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
615900000 USD
CY2019 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-292500000 USD
CY2018 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-561600000 USD
CY2021 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
22800000 USD
CY2019 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-1400000 USD
CY2018 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-53900000 USD
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
1083700000 USD
CY2019 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
3200000 USD
CY2018 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-343700000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
314600000 USD
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
311400000 USD
CY2017Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
655100000 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1398300000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
314600000 USD
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
311400000 USD
CY2021Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1381000000.0 USD
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
297700000 USD
CY2021Q1 us-gaap Restricted Cash And Investments Current
RestrictedCashAndInvestmentsCurrent
17300000 USD
CY2019Q4 us-gaap Restricted Cash And Investments Current
RestrictedCashAndInvestmentsCurrent
16900000 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1398300000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
314600000 USD
CY2017Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
8305000000.0 USD
CY2018 us-gaap Profit Loss
ProfitLoss
605800000 USD
CY2018 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-225200000 USD
CY2018 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
2.58
CY2018 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
384900000 USD
CY2018 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
941854 shares
CY2018 us-gaap Stock Issued During Period Value Treasury Stock Reissued
StockIssuedDuringPeriodValueTreasuryStockReissued
38500000 USD
CY2018 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
3677435 shares
CY2018 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
527100000 USD
CY2018 us-gaap Minority Interest Decrease From Redemptions
MinorityInterestDecreaseFromRedemptions
-300000 USD
CY2018 swk Purchase Of Call Options
PurchaseOfCallOptions
-57300000 USD
CY2018 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
76500000 USD
CY2018 swk Employee Stock Ownership Plan And Related Tax Benefit
EmployeeStockOwnershipPlanAndRelatedTaxBenefit
8300000 USD
CY2018Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
7839900000 USD
CY2019 us-gaap Profit Loss
ProfitLoss
958000000.0 USD
CY2019 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-70300000 USD
CY2019 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
2.70
CY2019 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
402000000.0 USD
CY2019 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
2391336 shares
CY2019 us-gaap Stock Issued During Period Value Treasury Stock Reissued
StockIssuedDuringPeriodValueTreasuryStockReissued
146000000.0 USD
CY2019 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
187377 shares
CY2019 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
27500000 USD
CY2019 us-gaap Accelerated Share Repurchase Program Adjustment
AcceleratedShareRepurchaseProgramAdjustment
734500000 USD
CY2019 us-gaap Minority Interest Decrease From Redemptions
MinorityInterestDecreaseFromRedemptions
114200000 USD
CY2019 us-gaap Minority Interest Decrease From Redemptions
MinorityInterestDecreaseFromRedemptions
114200000 USD
CY2019 swk Purchase Of Call Options
PurchaseOfCallOptions
-19200000 USD
CY2019 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
88800000 USD
CY2019 swk Employee Stock Ownership Plan And Related Tax Benefit
EmployeeStockOwnershipPlanAndRelatedTaxBenefit
8200000 USD
CY2019Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
9142200000 USD
CY2021 us-gaap Profit Loss
ProfitLoss
1234700000 USD
CY2021 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
170900000 USD
CY2021 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
170900000 USD
CY2021 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
2.78
CY2021 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
431800000 USD
CY2021 us-gaap Preferred Stock Dividends Per Share Cash Paid
PreferredStockDividendsPerShareCashPaid
50.00
CY2021 us-gaap Dividends Preferred Stock Cash
DividendsPreferredStockCash
23400000 USD
CY2021 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
7474394 shares
CY2021 us-gaap Stock Issued During Period Value Treasury Stock Reissued
StockIssuedDuringPeriodValueTreasuryStockReissued
897000000.0 USD
CY2021 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
228541 shares
CY2021 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
26200000 USD
CY2021 us-gaap Minority Interest Decrease From Redemptions
MinorityInterestDecreaseFromRedemptions
4600000 USD
CY2021 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
109100000 USD
CY2021 swk Employee Stock Ownership Plan And Related Tax Benefit
EmployeeStockOwnershipPlanAndRelatedTaxBenefit
2300000 USD
CY2021Q1 us-gaap Cumulative Effect Of New Accounting Principle In Period Of Adoption
CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption
-3800000 USD
CY2021Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
11066400000 USD
CY2021Q1 swk Disposal Of Business Countries Of Operations
DisposalOfBusinessCountriesOfOperations
5 country
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P4Y
CY2021 swk Share Based Compensation Arrangements By Share Based Payment Award Number Of Years Of Service For Eligibility
ShareBasedCompensationArrangementsByShareBasedPaymentAwardNumberOfYearsOfServiceForEligibility
P10Y
CY2021Q1 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
1345700000 USD
CY2019Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
1284000000.0 USD
CY2021Q1 us-gaap Notes And Loans Receivable Gross Current
NotesAndLoansReceivableGrossCurrent
156100000 USD
CY2019Q4 us-gaap Notes And Loans Receivable Gross Current
NotesAndLoansReceivableGrossCurrent
156700000 USD
CY2021Q1 us-gaap Other Receivables Gross Current
OtherReceivablesGrossCurrent
151500000 USD
CY2019Q4 us-gaap Other Receivables Gross Current
OtherReceivablesGrossCurrent
126300000 USD
CY2021Q1 swk Trade Accounts And Notes Receivable Gross Current
TradeAccountsAndNotesReceivableGrossCurrent
1653300000 USD
CY2019Q4 swk Trade Accounts And Notes Receivable Gross Current
TradeAccountsAndNotesReceivableGrossCurrent
1567000000.0 USD
CY2021Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
141100000 USD
CY2019Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
112400000 USD
CY2021Q1 us-gaap Accounts Notes And Loans Receivable Net Current
AccountsNotesAndLoansReceivableNetCurrent
1512200000 USD
CY2019Q4 us-gaap Accounts Notes And Loans Receivable Net Current
AccountsNotesAndLoansReceivableNetCurrent
1454600000 USD
CY2019Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
112400000 USD
CY2021 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
41100000 USD
CY2021 swk Accounts Receivable Credit Loss Expense Reversal Charged To Other Accounts
AccountsReceivableCreditLossExpenseReversalChargedToOtherAccounts
19900000 USD
CY2021 swk Accounts Receivable Allowance For Credit Loss Writeoff Recovery Net
AccountsReceivableAllowanceForCreditLossWriteoffRecoveryNet
-36100000 USD
CY2021Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
141100000 USD
CY2020Q3 us-gaap Financing Receivable Threshold Period Past Due Writeoff
FinancingReceivableThresholdPeriodPastDueWriteoff
P90D
CY2021Q1 us-gaap Capital Leases Future Minimum Payments Receivable
CapitalLeasesFutureMinimumPaymentsReceivable
209500000 USD
CY2021Q1 us-gaap Capital Leases Future Minimum Payments Receivable Current
CapitalLeasesFutureMinimumPaymentsReceivableCurrent
80300000 USD
CY2021Q1 us-gaap Capital Leases Future Minimum Payments Receivable In Two Years
CapitalLeasesFutureMinimumPaymentsReceivableInTwoYears
56500000 USD
CY2021Q1 us-gaap Capital Leases Future Minimum Payments Receivable In Three Years
CapitalLeasesFutureMinimumPaymentsReceivableInThreeYears
38900000 USD
CY2021Q1 us-gaap Capital Leases Future Minimum Payments Receivable In Four Years
CapitalLeasesFutureMinimumPaymentsReceivableInFourYears
21400000 USD
CY2021Q1 us-gaap Capital Leases Future Minimum Payments Receivable In Five Years
CapitalLeasesFutureMinimumPaymentsReceivableInFiveYears
8100000 USD
CY2021Q1 us-gaap Capital Leases Future Minimum Payments Receivable Due Thereafter
CapitalLeasesFutureMinimumPaymentsReceivableDueThereafter
4300000 USD
CY2021Q1 us-gaap Derecognized Assets Securitized Or Assetbacked Financing Arrangement Assets And Any Other Financial Assets Managed Together Principal Amount Outstanding
DerecognizedAssetsSecuritizedOrAssetbackedFinancingArrangementAssetsAndAnyOtherFinancialAssetsManagedTogetherPrincipalAmountOutstanding
86800000 USD
CY2019Q4 us-gaap Derecognized Assets Securitized Or Assetbacked Financing Arrangement Assets And Any Other Financial Assets Managed Together Principal Amount Outstanding
DerecognizedAssetsSecuritizedOrAssetbackedFinancingArrangementAssetsAndAnyOtherFinancialAssetsManagedTogetherPrincipalAmountOutstanding
100000000.0 USD
CY2021Q1 us-gaap Lessor Operating Lease Payments To Be Received
LessorOperatingLeasePaymentsToBeReceived
39700000 USD
CY2021Q1 us-gaap Operating Leases Future Minimum Payments Receivable Current
OperatingLeasesFutureMinimumPaymentsReceivableCurrent
38500000 USD
CY2021Q1 us-gaap Operating Leases Future Minimum Payments Receivable In Two Years
OperatingLeasesFutureMinimumPaymentsReceivableInTwoYears
900000 USD
CY2021Q1 us-gaap Operating Leases Future Minimum Payments Receivable In Three Years
OperatingLeasesFutureMinimumPaymentsReceivableInThreeYears
300000 USD
CY2021Q1 us-gaap Operating Leases Future Minimum Payments Receivable In Four Years
OperatingLeasesFutureMinimumPaymentsReceivableInFourYears
0 USD
CY2021Q1 us-gaap Operating Leases Future Minimum Payments Receivable In Five Years
OperatingLeasesFutureMinimumPaymentsReceivableInFiveYears
0 USD
CY2021Q1 us-gaap Operating Leases Future Minimum Payments Receivable Thereafter
OperatingLeasesFutureMinimumPaymentsReceivableThereafter
0 USD
CY2021 us-gaap Sales Type Lease Revenue
SalesTypeLeaseRevenue
113000000.0 USD
CY2019 us-gaap Sales Type Lease Revenue
SalesTypeLeaseRevenue
88900000 USD
CY2021 us-gaap Operating Leases Income Statement Lease Revenue
OperatingLeasesIncomeStatementLeaseRevenue
131500000 USD
CY2019 us-gaap Operating Leases Income Statement Lease Revenue
OperatingLeasesIncomeStatementLeaseRevenue
148900000 USD
CY2021 us-gaap Sales Type Lease Lease Income
SalesTypeLeaseLeaseIncome
45000000.0 USD
CY2019 us-gaap Sales Type Lease Lease Income
SalesTypeLeaseLeaseIncome
35300000 USD
CY2021 us-gaap Cash Flows Between Transferee And Transferor Proceeds From New Transfers
CashFlowsBetweenTransfereeAndTransferorProceedsFromNewTransfers
259600000 USD
CY2019 us-gaap Cash Flows Between Transferee And Transferor Proceeds From New Transfers
CashFlowsBetweenTransfereeAndTransferorProceedsFromNewTransfers
495400000 USD
CY2021 swk Cash Flows Between Transferor And Transferee Payment To Purchaser
CashFlowsBetweenTransferorAndTransfereePaymentToPurchaser
272800000 USD
CY2019 swk Cash Flows Between Transferor And Transferee Payment To Purchaser
CashFlowsBetweenTransferorAndTransfereePaymentToPurchaser
495500000 USD
CY2021 us-gaap Securitization Financial Asset For Which Transfer Is Accounted As Sale Gain Loss On Sale
SecuritizationFinancialAssetForWhichTransferIsAccountedAsSaleGainLossOnSale
-1700000 USD
CY2019 us-gaap Securitization Financial Asset For Which Transfer Is Accounted As Sale Gain Loss On Sale
SecuritizationFinancialAssetForWhichTransferIsAccountedAsSaleGainLossOnSale
-3600000 USD
CY2021 us-gaap Cash Flows Between Transferee And Transferor Servicing Fees
CashFlowsBetweenTransfereeAndTransferorServicingFees
600000 USD
CY2019 us-gaap Cash Flows Between Transferee And Transferor Servicing Fees
CashFlowsBetweenTransfereeAndTransferorServicingFees
900000 USD
CY2021Q1 us-gaap Deferred Revenue
DeferredRevenue
207600000 USD
CY2019Q4 us-gaap Deferred Revenue
DeferredRevenue
209800000 USD
CY2021Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
108700000 USD
CY2019Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
108900000 USD
CY2021 us-gaap Deferred Revenue Revenue Recognized1
DeferredRevenueRevenueRecognized1
96800000 USD
CY2019 us-gaap Deferred Revenue Revenue Recognized1
DeferredRevenueRevenueRecognized1
96400000 USD
CY2021Q1 us-gaap Customer Advances And Progress Payments For Long Term Contracts Or Programs
CustomerAdvancesAndProgressPaymentsForLongTermContractsOrPrograms
1107000000 USD
CY2021Q1 us-gaap Inventory Finished Goods
InventoryFinishedGoods
1922500000 USD
CY2019Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
1526000000.0 USD
CY2021Q1 us-gaap Inventory Work In Process
InventoryWorkInProcess
222300000 USD
CY2019Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
162000000.0 USD
CY2021Q1 us-gaap Inventory Raw Materials
InventoryRawMaterials
592600000 USD
CY2019Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
567000000.0 USD
CY2021Q1 us-gaap Inventory Net
InventoryNet
2737400000 USD
CY2019Q4 us-gaap Inventory Net
InventoryNet
2255000000.0 USD
CY2021Q1 us-gaap Lifo Inventory Amount
LIFOInventoryAmount
1300000000 USD
CY2019Q4 us-gaap Lifo Inventory Amount
LIFOInventoryAmount
1100000000 USD
CY2021Q1 us-gaap Excess Of Replacement Or Current Costs Over Stated Lifo Value
ExcessOfReplacementOrCurrentCostsOverStatedLIFOValue
52500000 USD
CY2019Q4 us-gaap Excess Of Replacement Or Current Costs Over Stated Lifo Value
ExcessOfReplacementOrCurrentCostsOverStatedLIFOValue
78100000 USD
CY2021Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
4679900000 USD
CY2019Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
4290800000 USD
CY2021Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2626100000 USD
CY2019Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2331300000 USD
CY2021Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2053800000 USD
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1959500000 USD
CY2021 us-gaap Depreciation
Depreciation
332600000 USD
CY2019 us-gaap Depreciation
Depreciation
325200000 USD
CY2018 us-gaap Depreciation
Depreciation
288400000 USD
CY2021 us-gaap Adjustment For Amortization
AdjustmentForAmortization
43900000 USD
CY2019 us-gaap Adjustment For Amortization
AdjustmentForAmortization
47600000 USD
CY2018 us-gaap Adjustment For Amortization
AdjustmentForAmortization
42800000 USD
CY2021 us-gaap Depreciation And Amortization
DepreciationAndAmortization
376500000 USD
CY2019 us-gaap Depreciation And Amortization
DepreciationAndAmortization
372800000 USD
CY2018 us-gaap Depreciation And Amortization
DepreciationAndAmortization
331200000 USD
CY2021 us-gaap Number Of Businesses Acquired
NumberOfBusinessesAcquired
1 Acquisition
CY2021 us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
14592600000 USD
CY2019 us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
14903700000 USD
CY2021 us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
1256700000 USD
CY2019 us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
923000000.0 USD
CY2021 us-gaap Business Acquisition Pro Forma Earnings Per Share Diluted
BusinessAcquisitionProFormaEarningsPerShareDiluted
8.06
CY2019 us-gaap Business Acquisition Pro Forma Earnings Per Share Diluted
BusinessAcquisitionProFormaEarningsPerShareDiluted
6.13
CY2018Q4 us-gaap Goodwill
Goodwill
8956700000 USD
CY2019 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
327400000 USD
CY2019 us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
-46600000 USD
CY2019Q4 us-gaap Goodwill
Goodwill
9237500000 USD
CY2021 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
650700000 USD
CY2018 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
175300000 USD
CY2021Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
201800000 USD
CY2021Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
192700000 USD
CY2021Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
183900000 USD
CY2021Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
175400000 USD
CY2021Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
156900000 USD
CY2021 us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
149900000 USD
CY2021Q1 us-gaap Goodwill
Goodwill
10038100000 USD
CY2021Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
3867800000 USD
CY2021Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
2010000000.0 USD
CY2019Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
3209000000.0 USD
CY2019Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1773300000 USD
CY2021Q1 us-gaap Indefinite Lived Trade Names
IndefiniteLivedTradeNames
2198000000 USD
CY2019Q4 us-gaap Indefinite Lived Trade Names
IndefiniteLivedTradeNames
2186000000 USD
CY2021 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
201600000 USD
CY2019 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
187400000 USD
CY2021Q1 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
947100000 USD
CY2021Q1 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
324200000 USD
CY2019Q4 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
262400000 USD
CY2021Q1 swk Accrued Income Taxes And Other Current
AccruedIncomeTaxesAndOtherCurrent
241000000.0 USD
CY2019Q4 swk Accrued Income Taxes And Other Current
AccruedIncomeTaxesAndOtherCurrent
243900000 USD
CY2021Q1 swk Accrued Rebates And Returns
AccruedRebatesAndReturns
229600000 USD
CY2019Q4 swk Accrued Rebates And Returns
AccruedRebatesAndReturns
112000000.0 USD
CY2021Q1 us-gaap Accrued Insurance Current
AccruedInsuranceCurrent
80400000 USD
CY2019Q4 us-gaap Accrued Insurance Current
AccruedInsuranceCurrent
69800000 USD
CY2021Q1 us-gaap Restructuring Reserve Current
RestructuringReserveCurrent
90200000 USD
CY2019Q4 us-gaap Restructuring Reserve Current
RestructuringReserveCurrent
147800000 USD
CY2021Q1 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
185300000 USD
CY2019Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
22400000 USD
CY2021Q1 us-gaap Standard Product Warranty Accrual Current
StandardProductWarrantyAccrualCurrent
81500000 USD
CY2019Q4 us-gaap Standard Product Warranty Accrual Current
StandardProductWarrantyAccrualCurrent
69600000 USD
CY2021Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
108700000 USD
CY2019Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
108900000 USD
CY2019Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
141300000 USD
CY2021Q1 swk Accruedfreightcosts
Accruedfreightcosts
93500000 USD
CY2019Q4 swk Accruedfreightcosts
Accruedfreightcosts
72900000 USD
CY2021Q1 us-gaap Accrual For Environmental Loss Contingencies
AccrualForEnvironmentalLossContingencies
46700000 USD
CY2019Q4 us-gaap Accrual For Environmental Loss Contingencies
AccrualForEnvironmentalLossContingencies
57800000 USD
CY2021Q1 us-gaap Other Accrued Liabilities Current And Noncurrent
OtherAccruedLiabilitiesCurrentAndNoncurrent
0 USD
CY2019Q4 us-gaap Other Accrued Liabilities Current And Noncurrent
OtherAccruedLiabilitiesCurrentAndNoncurrent
249200000 USD
CY2021Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
138800000 USD
CY2021Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
490500000 USD
CY2019Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
419500000 USD
CY2021Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2110400000 USD
CY2019Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1977500000 USD
CY2021Q1 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
4300000000 USD
CY2021Q1 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
5800000 USD
CY2021Q1 us-gaap Deferred Gain Loss On Discontinuation Of Fair Value Hedge
DeferredGainLossOnDiscontinuationOfFairValueHedge
-20800000 USD
CY2021 us-gaap Liabilities Fair Value Adjustment
LiabilitiesFairValueAdjustment
7900000 USD
CY2021Q1 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
35900000 USD
CY2021Q1 us-gaap Long Term Debt
LongTermDebt
4245400000 USD
CY2019Q4 us-gaap Long Term Debt
LongTermDebt
3179500000 USD
CY2021Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
0 USD
CY2019Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
3100000 USD
CY2021Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
4245400000 USD
CY2019Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
3176400000 USD
CY2021Q1 us-gaap Long Term Debt Maturities Repayments Of Principal After Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive
4300000000 USD
CY2021Q1 swk Fair Value Adjustment Of Interest Rate Swap
FairValueAdjustmentOfInterestRateSwap
26600000 USD
CY2021Q1 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
35900000 USD
CY2021 us-gaap Interest Paid
InterestPaid
192100000 USD
CY2019 us-gaap Interest Paid
InterestPaid
252900000 USD
CY2018 us-gaap Interest Paid
InterestPaid
249600000 USD
CY2020Q4 us-gaap Deferred Finance Costs Gross
DeferredFinanceCostsGross
10100000 USD
CY2021 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
990000000.0 USD
CY2021Q1 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
900000 USD
CY2021 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
9100000 USD
CY2018Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
977500000 USD
CY2018Q1 swk Commercial Paper Maximum Borrowing Capacity
CommercialPaperMaximumBorrowingCapacity
3000000000.0 USD
CY2019Q3 swk Commercial Paper Maximum Borrowing Capacity
CommercialPaperMaximumBorrowingCapacity
3000000000.0 USD
CY2021Q1 swk Commercial Paper Maximum Borrowing Capacity
CommercialPaperMaximumBorrowingCapacity
3000000000.0 USD
CY2021Q1 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
3500000000 USD
CY2020Q2 swk Debt Instrument Convenant Interest Coverage Ratio
DebtInstrumentConvenantInterestCoverageRatio
3.5 Rate
CY2021 swk Paymentsfor Proceedsfrom Derivative Instruments
PaymentsforProceedsfromDerivativeInstruments
33400000 USD
CY2019 swk Paymentsfor Proceedsfrom Derivative Instruments
PaymentsforProceedsfromDerivativeInstruments
69900000 USD
CY2018 swk Paymentsfor Proceedsfrom Derivative Instruments
PaymentsforProceedsfromDerivativeInstruments
2400000 USD
CY2021 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
9566700000 USD
CY2021 us-gaap Interest Expense
InterestExpense
223100000 USD
CY2019 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
9636700000 USD
CY2019 us-gaap Interest Expense
InterestExpense
284300000 USD
CY2018 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
9131300000 USD
CY2018 us-gaap Interest Expense
InterestExpense
277900000 USD
CY2021 us-gaap Interest Expense
InterestExpense
223100000 USD
CY2019 us-gaap Interest Expense
InterestExpense
284300000 USD
CY2018 us-gaap Interest Expense
InterestExpense
277900000 USD
CY2020Q4 us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax
3500000 USD
CY2019Q1 us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax
4600000 USD
CY2021Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
0 USD
CY2021Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
4245400000 USD
CY2021 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
1210400000 USD
CY2019 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
955800000 USD
CY2018 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
605200000 USD
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
154176000 shares
CY2019 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
148365000 shares
CY2018 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
148919000 shares
CY2021 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
1685000 shares
CY2019 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
2193000 shares
CY2018 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
2724000 shares
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
155861000 shares
CY2019 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
150558000 shares
CY2018 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
151643000 shares
CY2021Q1 us-gaap Stock Repurchase Program Number Of Shares Authorized To Be Repurchased
StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased
3645510 shares
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
7.85
CY2019 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
6.44
CY2018 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
4.06
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
7.77
CY2019 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
6.35
CY2018 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
3.99
swk Preferred Stock Conversion Rate Number Of Common Stock Shares
PreferredStockConversionRateNumberOfCommonStockShares
5.2263
us-gaap Option Indexed To Issuers Equity Strike Price1
OptionIndexedToIssuersEquityStrikePrice1
191.34
CY2021Q1 swk Preferred Stock Conversion Rate Number Of Common Stock Shares
PreferredStockConversionRateNumberOfCommonStockShares
5.2269
CY2021Q1 us-gaap Option Indexed To Issuers Equity Strike Price1
OptionIndexedToIssuersEquityStrikePrice1
191.32
CY2017Q2 swk Equityunitsissued
Equityunitsissued
7500000 shares
CY2017Q2 swk Equity Unit
EquityUnit
750000000.0 USD
CY2017Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
750000 shares
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
153506409 shares
CY2018Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
151302450 shares
CY2019Q4 us-gaap Stock Repurchase Program Number Of Shares Authorized To Be Repurchased
StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased
3645510 shares
CY2018Q4 us-gaap Stock Repurchase Program Number Of Shares Authorized To Be Repurchased
StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased
3645510 shares
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
153506409 shares
CY2018Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
151302450 shares
CY2017Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
154038031 shares
CY2021 us-gaap Stock Issued During Period Shares Treasury Stock Reissued
StockIssuedDuringPeriodSharesTreasuryStockReissued
7474394 shares
CY2019 us-gaap Stock Issued During Period Shares Treasury Stock Reissued
StockIssuedDuringPeriodSharesTreasuryStockReissued
2391336 shares
CY2018 us-gaap Stock Issued During Period Shares Treasury Stock Reissued
StockIssuedDuringPeriodSharesTreasuryStockReissued
941854 shares
CY2021 us-gaap Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
228541 shares
CY2019 us-gaap Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
187377 shares
CY2018 us-gaap Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
3677435 shares
CY2021Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
160752262 shares
CY2021Q1 swk Common Stock Shares Outstanding Excluding Shares Subject To Forward Purchase Contract
CommonStockSharesOutstandingExcludingSharesSubjectToForwardPurchaseContract
157106752 shares
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
104300000 USD
CY2021Q1 swk Equityunitsissued
Equityunitsissued
7500000 shares
CY2019Q4 swk Common Stock Shares Outstanding Excluding Shares Subject To Forward Purchase Contract
CommonStockSharesOutstandingExcludingSharesSubjectToForwardPurchaseContract
149860899 shares
CY2018Q4 swk Common Stock Shares Outstanding Excluding Shares Subject To Forward Purchase Contract
CommonStockSharesOutstandingExcludingSharesSubjectToForwardPurchaseContract
147656940 shares
CY2020Q2 us-gaap Conversion Of Stock Shares Issued1
ConversionOfStockSharesIssued1
5463750 shares
CY2018Q2 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
1399732 shares
CY2018Q2 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
200000000.0 USD
CY2018Q3 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
2086792 shares
CY2018Q3 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
300000000.0 USD
CY2016Q2 us-gaap Stock Repurchase Program Number Of Shares Authorized To Be Repurchased
StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased
3645510 shares
CY2016Q2 us-gaap Payments For Repurchase Of Equity
PaymentsForRepurchaseOfEquity
350000000.0 USD
CY2021Q1 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
9594743 shares
CY2019Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
12924290 shares
CY2021 swk Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Historical Volatility Term
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsHistoricalVolatilityTerm
P5Y3M
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
6454671 shares
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
122.42
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
1103538 shares
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
179.85
CY2021 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
1419699 shares
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
94.24
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
263264 shares
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
148.68
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
5875246 shares
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
138.84
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
3289889 shares
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
121.65
CY2021 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
133800000 USD
CY2021 us-gaap Employee Service Share Based Compensation Tax Benefit From Exercise Of Stock Options
EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions
24600000 USD
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
143700000 USD
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
18300000 USD
CY2021 us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
17600000 USD
CY2019 us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
25800000 USD
CY2018 us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
2300000 USD
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
5875246 shares
CY2021 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
P7Y1M17D
CY2021Q1 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
138.84
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
3289889 shares
CY2021 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2
P5Y7M28D
CY2021Q1 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
121.65
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
234800000 USD
CY2021Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
187200000 USD
CY2021 us-gaap Stock Granted During Period Value Sharebased Compensation Gross
StockGrantedDuringPeriodValueSharebasedCompensationGross
1600000 USD
CY2019 us-gaap Stock Granted During Period Value Sharebased Compensation Gross
StockGrantedDuringPeriodValueSharebasedCompensationGross
6800000 USD
CY2018 us-gaap Stock Granted During Period Value Sharebased Compensation Gross
StockGrantedDuringPeriodValueSharebasedCompensationGross
3400000 USD
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
346011 shares
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
127.27
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
508860 shares
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
93.58
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
62613 shares
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
127.27
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
199223 shares
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
122.60
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
593035 shares
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
99.93
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Requisite Service Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1
P3Y
CY2021 swk Earnings Per Share And Return On Capital Employed As Percentage Of Share Based Payment
EarningsPerShareAndReturnOnCapitalEmployedAsPercentageOfShareBasedPayment
0.75
CY2021 swk Market Based Elements As Percentage Of Share Based Payment
MarketBasedElementsAsPercentageOfShareBasedPayment
0.25
CY2021 swk Market Based Elements As Percentage Of Share Based Payment
MarketBasedElementsAsPercentageOfShareBasedPayment
0.25
CY2021 swk Purchase Of Call Options
PurchaseOfCallOptions
-19200000 USD
CY2018Q2 swk Equityunitsissued
Equityunitsissued
7500000 shares
CY2021Q1 swk Equity Unit
EquityUnit
750000000.0 USD
CY2019Q4 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
100
us-gaap Forward Contract Indexed To Issuers Equity Forward Rate
ForwardContractIndexedToIssuersEquityForwardRate
100
CY2021Q1 us-gaap Preferred Stock Liquidation Preference
PreferredStockLiquidationPreference
1000
CY2021Q1 swk Equityunitproceeds
Equityunitproceeds
735000000.0 USD
CY2021Q1 us-gaap Preferred Stock Liquidation Preference Value
PreferredStockLiquidationPreferenceValue
750000000.0 USD
swk Purchase Of Call Options
PurchaseOfCallOptions
19200000 USD
CY2021Q1 us-gaap Preferred Stock Liquidation Preference
PreferredStockLiquidationPreference
1000
CY2019Q4 swk Preferred Stock Conversion Rate Number Of Common Stock Shares
PreferredStockConversionRateNumberOfCommonStockShares
5.2263
CY2019Q4 us-gaap Option Indexed To Issuers Equity Strike Price1
OptionIndexedToIssuersEquityStrikePrice1
191.34
CY2021Q1 swk Preferred Stock Conversion Rate Number Of Common Stock Shares
PreferredStockConversionRateNumberOfCommonStockShares
5.2269
CY2021Q1 us-gaap Option Indexed To Issuers Equity Strike Price1
OptionIndexedToIssuersEquityStrikePrice1
191.32
CY2019Q4 swk Preferred Stock Redemption Percentage
PreferredStockRedemptionPercentage
1
us-gaap Forward Contract Indexed To Issuers Equity Shares
ForwardContractIndexedToIssuersEquityShares
4700000 shares
swk Equity Units Conversion Rate Number Of Common Stock Shares
EquityUnitsConversionRateNumberOfCommonStockShares
0.6272 shares
CY2019Q4 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
159.45
CY2021Q1 swk Equity Units Conversion Rate Number Of Common Stock Shares
EquityUnitsConversionRateNumberOfCommonStockShares
0.6272 shares
CY2021Q1 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
159.43
us-gaap Forward Contract Indexed To Issuers Equity Forward Rate
ForwardContractIndexedToIssuersEquityForwardRate
100
CY2019Q4 us-gaap Forward Contract Indexed To Issuers Equity Settlement Alternatives Cash At Fair Value
ForwardContractIndexedToIssuersEquitySettlementAlternativesCashAtFairValue
114200000 USD
CY2020Q4 swk Preferred Shares Deliverable Upon Early Settlement Of Purchase Contracts
PreferredSharesDeliverableUponEarlySettlementOfPurchaseContracts
0.85
swk Preferred Stock Conversion Rate Number Of Common Stock Shares
PreferredStockConversionRateNumberOfCommonStockShares
5.2263
CY2019Q4 swk Upper Strike Percentage Against Closing Price
UpperStrikePercentageAgainstClosingPrice
0.30
CY2021 us-gaap Option Indexed To Issuers Equity Shares
OptionIndexedToIssuersEquityShares
3900000 shares
CY2018Q2 swk Equity Unit
EquityUnit
750000000.0 USD
CY2018Q2 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
100
CY2021 swk Purchase Of Call Options
PurchaseOfCallOptions
-19200000 USD
CY2018Q2 us-gaap Forward Contract Indexed To Issuers Equity Forward Rate
ForwardContractIndexedToIssuersEquityForwardRate
100
CY2018Q2 us-gaap Preferred Stock Liquidation Preference
PreferredStockLiquidationPreference
1000
CY2018Q2 swk Equityunitproceeds
Equityunitproceeds
726000000.0 USD
CY2018Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
750000 shares
CY2018Q2 us-gaap Preferred Stock Liquidation Preference Value
PreferredStockLiquidationPreferenceValue
750000000.0 USD
CY2018Q2 swk Purchase Of Call Options
PurchaseOfCallOptions
25100000 USD
CY2018Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
750000 shares
CY2018Q3 us-gaap Preferred Stock Liquidation Preference
PreferredStockLiquidationPreference
1000
CY2021 swk Preferred Stock Conversion Rate Number Of Common Stock Shares
PreferredStockConversionRateNumberOfCommonStockShares
6.7504
CY2020Q2 us-gaap Preferred Stock Dividend Rate Percentage
PreferredStockDividendRatePercentage
0.050
CY2020Q2 us-gaap Preferred Stock Liquidation Preference
PreferredStockLiquidationPreference
1000
CY2020Q2 us-gaap Preferred Stock Dividend Rate Per Dollar Amount
PreferredStockDividendRatePerDollarAmount
50.00
CY2021 swk Preferred Stock Redemption Percentage
PreferredStockRedemptionPercentage
1
CY2020Q2 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
750000000.0 USD
CY2020Q2 us-gaap Conversion Of Stock Shares Issued1
ConversionOfStockSharesIssued1
5463750 shares
CY2020Q2 us-gaap Convertible Preferred Stock Shares Issued Upon Conversion
ConvertiblePreferredStockSharesIssuedUponConversion
0.7285 shares
CY2020Q2 swk Preferred Stock Convertible Conversion Price
PreferredStockConvertibleConversionPrice
137.26
CY2021Q1 us-gaap Derivative Forward Interest Rate
DerivativeForwardInterestRate
0.05375
CY2017Q2 us-gaap Forward Contract Indexed To Issuers Equity Settlement Alternatives Cash At Fair Value
ForwardContractIndexedToIssuersEquitySettlementAlternativesCashAtFairValue
117100000 USD
CY2021 us-gaap Accretion Expense
AccretionExpense
1300000 USD
CY2017Q2 swk Options Indexed To Issuers Equity Number Of Counterparties
OptionsIndexedToIssuersEquityNumberOfCounterparties
3 financial_institution
CY2017Q2 swk Option Indexed To Issuers Equity Term
OptionIndexedToIssuersEquityTerm
P3Y
CY2017Q2 swk Preferred Stock Conversion Rate Number Of Common Stock Shares
PreferredStockConversionRateNumberOfCommonStockShares
6.1627
CY2020Q1 swk Option Indexed To Issuers Equity Settlement Alternatives Average Reference Price
OptionIndexedToIssuersEquitySettlementAlternativesAverageReferencePrice
162.26
CY2018Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1814300000 USD
CY2019 us-gaap Other Comprehensive Income Loss Before Reclassifications Net Of Tax
OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
-69800000 USD
CY2019 us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
500000 USD
CY2019 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-70300000 USD
CY2019Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1884600000 USD
CY2021 us-gaap Other Comprehensive Income Loss Before Reclassifications Net Of Tax
OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
110300000 USD
CY2021 swk Other Comprehensive Income Loss Adjustments For Disposition Of Business
OtherComprehensiveIncomeLossAdjustmentsForDispositionOfBusiness
16300000 USD
CY2021 us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
-44300000 USD
CY2021 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
170900000 USD
CY2021Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1713700000 USD
CY2021 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
700000 USD
CY2021 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
5600000 USD
CY2019 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
28800000 USD
CY2018 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
29000000.0 USD
CY2019 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
7200000 USD
CY2018 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
7000000.0 USD
CY2019Q4 us-gaap Employee Stock Ownership Plan Esop Shares In Esop
EmployeeStockOwnershipPlanESOPSharesInESOP
226212 shares
CY2018Q4 us-gaap Employee Stock Ownership Plan Esop Shares In Esop
EmployeeStockOwnershipPlanESOPSharesInESOP
207049 shares
CY2021 us-gaap Employee Stock Ownership Plan Esop Gain Loss On Transactions In Deferred Shares
EmployeeStockOwnershipPlanESOPGainLossOnTransactionsInDeferredShares
-6300000 USD
CY2019 us-gaap Employee Stock Ownership Plan Esop Gain Loss On Transactions In Deferred Shares
EmployeeStockOwnershipPlanESOPGainLossOnTransactionsInDeferredShares
-500000 USD
CY2018 us-gaap Employee Stock Ownership Plan Esop Gain Loss On Transactions In Deferred Shares
EmployeeStockOwnershipPlanESOPGainLossOnTransactionsInDeferredShares
-400000 USD
CY2019 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
7200000 USD
CY2018 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
7000000.0 USD
CY2021 us-gaap Multiemployer Plan Contributions By Employer
MultiemployerPlanContributionsByEmployer
7800000 USD
CY2019 us-gaap Multiemployer Plan Contributions By Employer
MultiemployerPlanContributionsByEmployer
7200000 USD
CY2018 us-gaap Multiemployer Plan Contributions By Employer
MultiemployerPlanContributionsByEmployer
7300000 USD
CY2021 us-gaap Defined Benefit Plan Other Costs
DefinedBenefitPlanOtherCosts
29700000 USD
CY2019 us-gaap Defined Benefit Plan Other Costs
DefinedBenefitPlanOtherCosts
36200000 USD
CY2018 us-gaap Defined Benefit Plan Other Costs
DefinedBenefitPlanOtherCosts
12900000 USD
CY2021 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Net Unamortized Gain Loss Arising During Period Before Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax
51900000 USD
CY2021 swk Defined Benefit Plan Other Comprehensive Income Amortization Of Actuarial Gain Loss During Period Before Tax
DefinedBenefitPlanOtherComprehensiveIncomeAmortizationOfActuarialGainLossDuringPeriodBeforeTax
-19500000 USD
CY2021 us-gaap Other Comprehensive Income Defined Benefit Plan Net Prior Service Cost Credit Arising During Period Before Tax
OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax
-200000 USD
CY2021 us-gaap Defined Benefit Plan Recognized Net Gain Loss Due To Settlements And Curtailments1
DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1
-600000 USD
CY2021 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
18400000 USD
CY2021 us-gaap Defined Benefit Plan Amounts Recognized In Other Comprehensive Income Loss Net Gain Loss Before Tax
DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossNetGainLossBeforeTax
50400000 USD
CY2021Q1 us-gaap Defined Benefit Plan Expected Amortization Next Fiscal Year
DefinedBenefitPlanExpectedAmortizationNextFiscalYear
22300000 USD
CY2021Q1 us-gaap Defined Benefit Plan Accumulated Benefit Obligation
DefinedBenefitPlanAccumulatedBenefitObligation
3022000000.000 USD
CY2019Q4 us-gaap Defined Benefit Plan Accumulated Benefit Obligation
DefinedBenefitPlanAccumulatedBenefitObligation
2768000000 USD
CY2021Q1 swk Defined Benefit Plan Pension Plans With Projected Benefit Obligations In Excess Of Plan Assets Aggregate Projected Benefit Obligation
DefinedBenefitPlanPensionPlansWithProjectedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation
1619900000 USD
CY2019Q4 swk Defined Benefit Plan Pension Plans With Projected Benefit Obligations In Excess Of Plan Assets Aggregate Projected Benefit Obligation
DefinedBenefitPlanPensionPlansWithProjectedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation
1448600000 USD
CY2021Q1 swk Defined Benefit Plan Pension Plans With Projected Benefit Obligations In Excess Of Plan Assets Aggregate Fair Value Of Plan Assets
DefinedBenefitPlanPensionPlansWithProjectedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets
1227000000.0 USD
CY2019Q4 swk Defined Benefit Plan Pension Plans With Projected Benefit Obligations In Excess Of Plan Assets Aggregate Fair Value Of Plan Assets
DefinedBenefitPlanPensionPlansWithProjectedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets
1092000000.0 USD
CY2021 us-gaap Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Expected Long Term Return On Assets
DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets
0.0316
CY2021 swk Defined Benefit Plan Percentage Of Pension Liability Invested In Fixed Income Securities
DefinedBenefitPlanPercentageOfPensionLiabilityInvestedInFixedIncomeSecurities
0.50
CY2021 swk Defined Benefit Plan Target Allocation Percentage Of Assetsequity Securities Range Minimum
DefinedBenefitPlanTargetAllocationPercentageOfAssetsequitySecuritiesRangeMinimum
0.20
CY2021 swk Defined Benefit Plan Target Allocation Percentage Of Assetsequity Securities Range Maximum
DefinedBenefitPlanTargetAllocationPercentageOfAssetsequitySecuritiesRangeMaximum
0.40
CY2021Q1 us-gaap Defined Benefit Plan Health Care Cost Trend Rate Assumed Next Fiscal Year
DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear
0.060
CY2021 swk Defined Benefit Plan Target Allocation Percentage Of Assets Fixed Income Securities Range Minimum
DefinedBenefitPlanTargetAllocationPercentageOfAssetsFixedIncomeSecuritiesRangeMinimum
0.50
CY2021 swk Defined Benefit Plan Target Allocation Percentage Of Assets Fixed Income Securities Range Maximum
DefinedBenefitPlanTargetAllocationPercentageOfAssetsFixedIncomeSecuritiesRangeMaximum
0.70
CY2021 swk Defined Benefit Plan Target Allocation Percentage Of Assets Alternative Investments Range Maximum
DefinedBenefitPlanTargetAllocationPercentageOfAssetsAlternativeInvestmentsRangeMaximum
0.10
CY2021Q1 us-gaap Defined Benefit Plan Funded Percentage
DefinedBenefitPlanFundedPercentage
0.80
CY2019Q4 us-gaap Defined Benefit Plan Funded Percentage
DefinedBenefitPlanFundedPercentage
0.79
CY2018Q4 us-gaap Defined Benefit Plan Funded Percentage
DefinedBenefitPlanFundedPercentage
0.78
CY2021Q1 us-gaap Defined Benefit Plan Expected Future Employer Contributions Next Fiscal Year
DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear
41000000 USD
CY2021 swk Defined Benefit Plan Expected Future Benefit Paymentsten Fiscal Years Thereafter
DefinedBenefitPlanExpectedFutureBenefitPaymentstenFiscalYearsThereafter
P10Y
CY2021Q1 swk Defined Benefit Plan Expected Future Benefit Payments
DefinedBenefitPlanExpectedFutureBenefitPayments
1440200000 USD
CY2021Q1 us-gaap Defined Benefit Plan Expected Future Benefit Payments Next Twelve Months
DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths
146500000 USD
CY2021Q1 us-gaap Defined Benefit Plan Expected Future Benefit Payments Year Two
DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo
146400000 USD
CY2021Q1 us-gaap Defined Benefit Plan Expected Future Benefit Payments Year Three
DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree
148600000 USD
CY2021Q1 us-gaap Defined Benefit Plan Expected Future Benefit Payments Year Four
DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour
146400000 USD
CY2021Q1 us-gaap Defined Benefit Plan Expected Future Benefit Payments Year Five
DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive
144600000 USD
CY2021Q1 us-gaap Defined Benefit Plan Expected Future Benefit Payments Five Fiscal Years Thereafter
DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter
707700000 USD
CY2021Q1 us-gaap Defined Benefit Plan Ultimate Health Care Cost Trend Rate1
DefinedBenefitPlanUltimateHealthCareCostTrendRate1
0.046
CY2021Q1 us-gaap Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
13900000 USD
CY2019Q4 us-gaap Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
14800000 USD
CY2021Q1 us-gaap Long Term Debt Fair Value
LongTermDebtFairValue
4934500000 USD
CY2019Q4 us-gaap Long Term Debt Fair Value
LongTermDebtFairValue
3601000000.0 USD
CY2021 us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
45900000 USD
CY2020Q2 us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
33000000.0 USD
CY2020Q2 swk Number Of Quarters
NumberOfQuarters
12 quarter
CY2021Q1 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
187000000.0 USD
CY2019Q4 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
196100000 USD
CY2021Q1 swk Sensitivity Analysisof Fair Value Contingent Consideration Liability Impactof10 Percent Adverse Changein Discount Rate
SensitivityAnalysisofFairValueContingentConsiderationLiabilityImpactof10PercentAdverseChangeinDiscountRate
7400000 USD
CY2021 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
211000000.0 USD
CY2019 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
255200000 USD
CY2018 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
275800000 USD
CY2019Q4 us-gaap Restructuring Reserve
RestructuringReserve
147800000 USD
CY2021 us-gaap Restructuring Charges
RestructuringCharges
83000000.0 USD
CY2021 us-gaap Payments For Restructuring
PaymentsForRestructuring
134900000 USD
CY2021 us-gaap Restructuring Reserve Translation Adjustment
RestructuringReserveTranslationAdjustment
-5700000 USD
CY2021Q1 us-gaap Restructuring Reserve
RestructuringReserve
90200000 USD
CY2021Q1 us-gaap Restructuring Reserve
RestructuringReserve
90200000 USD
CY2021 us-gaap Restructuring Charges
RestructuringCharges
83000000 USD
CY2021 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
3 Segment
CY2021 us-gaap Revenues
Revenues
14534600000 USD
CY2019 us-gaap Revenues
Revenues
14442200000 USD
CY2018 us-gaap Revenues
Revenues
13982400000 USD
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
2176000000.0 USD
CY2019 us-gaap Operating Income Loss
OperatingIncomeLoss
1994000000.0 USD
CY2018 us-gaap Operating Income Loss
OperatingIncomeLoss
1882200000 USD
CY2021 swk Corporate Overhead Expense
CorporateOverheadExpense
297700000 USD
CY2019 swk Corporate Overhead Expense
CorporateOverheadExpense
229500000 USD
CY2018 swk Corporate Overhead Expense
CorporateOverheadExpense
202800000 USD
CY2021 us-gaap Other Noninterest Expense
OtherNoninterestExpense
262800000 USD
CY2019 us-gaap Other Noninterest Expense
OtherNoninterestExpense
249100000 USD
CY2018 us-gaap Other Noninterest Expense
OtherNoninterestExpense
287000000.0 USD
CY2021 us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
-13500000 USD
CY2019 us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
17000000.0 USD
CY2018 us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
-800000 USD
CY2021 us-gaap Restructuring Settlement And Impairment Provisions
RestructuringSettlementAndImpairmentProvisions
83000000.0 USD
CY2019 us-gaap Restructuring Settlement And Impairment Provisions
RestructuringSettlementAndImpairmentProvisions
154100000 USD
CY2018 us-gaap Restructuring Settlement And Impairment Provisions
RestructuringSettlementAndImpairmentProvisions
160300000 USD
CY2021 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-46900000 USD
CY2019 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-17900000 USD
CY2018 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
CY2021 us-gaap Investment Income Interest
InvestmentIncomeInterest
18000000.0 USD
CY2019 us-gaap Investment Income Interest
InvestmentIncomeInterest
53900000 USD
CY2018 us-gaap Investment Income Interest
InvestmentIncomeInterest
68700000 USD
CY2021 us-gaap Interest Expense
InterestExpense
223100000 USD
CY2019 us-gaap Interest Expense
InterestExpense
284300000 USD
CY2018 us-gaap Interest Expense
InterestExpense
277900000 USD
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
1267000000.0 USD
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
1130000000.0 USD
CY2018 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
1022100000 USD
CY2021 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
348100000 USD
CY2019 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
424700000 USD
CY2018 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
492100000 USD
CY2021Q1 us-gaap Assets
Assets
23566300000 USD
CY2019Q4 us-gaap Assets
Assets
20596600000 USD
CY2018Q4 us-gaap Assets
Assets
19408000000.0 USD
CY2021 us-gaap Revenues
Revenues
14534600000 USD
CY2019 us-gaap Revenues
Revenues
14442200000 USD
CY2018 us-gaap Revenues
Revenues
13982400000 USD
CY2021Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2053800000 USD
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1959500000 USD
CY2018Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1915200000 USD
CY2021Q1 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
148900000 USD
CY2019Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
144900000 USD
CY2021Q1 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
741400000 USD
CY2019Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
737100000 USD
CY2021Q1 us-gaap Deferred Tax Liabilities Undistributed Foreign Earnings
DeferredTaxLiabilitiesUndistributedForeignEarnings
29700000 USD
CY2019Q4 us-gaap Deferred Tax Liabilities Undistributed Foreign Earnings
DeferredTaxLiabilitiesUndistributedForeignEarnings
159300000 USD
CY2021Q1 us-gaap Deferred Tax Liabilities Leasing Arrangements
DeferredTaxLiabilitiesLeasingArrangements
126500000 USD
CY2019Q4 us-gaap Deferred Tax Liabilities Leasing Arrangements
DeferredTaxLiabilitiesLeasingArrangements
129700000 USD
CY2021Q1 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
128300000 USD
CY2019Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
89500000 USD
CY2021Q1 swk Deferred Tax Liabilities Gross
DeferredTaxLiabilitiesGross
1174800000 USD
CY2019Q4 swk Deferred Tax Liabilities Gross
DeferredTaxLiabilitiesGross
1260500000 USD
CY2019Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits
235400000 USD
CY2021Q1 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits
244200000 USD
CY2021Q1 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
89700000 USD
CY2019Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
82000000.0 USD
CY2021Q1 swk Deferred Tax Assets Operating Loss And Capital Loss Carryforwards
DeferredTaxAssetsOperatingLossAndCapitalLossCarryforwards
808700000 USD
CY2019Q4 swk Deferred Tax Assets Operating Loss And Capital Loss Carryforwards
DeferredTaxAssetsOperatingLossAndCapitalLossCarryforwards
1100300000 USD
CY2021Q1 us-gaap Lease Incentive Receivable
LeaseIncentiveReceivable
129600000 USD
CY2019Q4 us-gaap Lease Incentive Receivable
LeaseIncentiveReceivable
129600000 USD
CY2021Q1 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
301300000 USD
CY2019Q4 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
5300000 USD
CY2021Q1 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
52600000 USD
CY2019Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
0 USD
CY2021Q1 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
217400000 USD
CY2019Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
149200000 USD
CY2021Q1 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
1843500000 USD
CY2019Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
1701800000 USD
CY2021Q1 swk Deferred Tax Assets Liabilities Gross
DeferredTaxAssetsLiabilitiesGross
668700000 USD
CY2019Q4 swk Deferred Tax Assets Liabilities Gross
DeferredTaxAssetsLiabilitiesGross
441300000 USD
CY2021Q1 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
1058900000 USD
CY2019Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
1065000000.0 USD
CY2021Q1 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
390200000 USD
CY2019Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
623700000 USD
CY2021Q1 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
1058900000 USD
CY2019Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
1065000000.0 USD
CY2021 us-gaap Undistributed Earnings
UndistributedEarnings
5300000000 USD
CY2021Q1 us-gaap Deferred Tax Liabilities Undistributed Foreign Earnings
DeferredTaxLiabilitiesUndistributedForeignEarnings
29700000 USD
CY2021Q1 us-gaap Undistributed Earnings Of Foreign Subsidiaries
UndistributedEarningsOfForeignSubsidiaries
2200000000 USD
CY2021Q1 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
3200000000 USD
CY2021Q1 us-gaap Deferred Tax Assets Capital Loss Carryforwards
DeferredTaxAssetsCapitalLossCarryforwards
38800000 USD
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
181200000 USD
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
214500000 USD
CY2018 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
444100000 USD
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
1085800000 USD
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
915500000 USD
CY2018 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
578000000.0 USD
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
1267000000.0 USD
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
1130000000.0 USD
CY2018 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
1022100000 USD
CY2021 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
62700000 USD
CY2019 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
-23700000 USD
CY2018 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
25400000 USD
CY2021 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
199800000 USD
CY2019 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
195900000 USD
CY2018 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
175000000.0 USD
CY2021 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
20600000 USD
CY2019 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
6500000 USD
CY2018 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
24800000 USD
CY2021 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
283100000 USD
CY2019 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
178700000 USD
CY2018 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
225200000 USD
CY2021 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-29400000 USD
CY2019 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
5700000 USD
CY2018 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
29700000 USD
CY2021 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
-208800000 USD
CY2019 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
-32900000 USD
CY2018 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
132700000 USD
CY2021 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-3500000 USD
CY2019 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
9300000 USD
CY2018 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
28700000 USD
CY2021 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-241700000 USD
CY2019 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-17900000 USD
CY2018 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
191100000 USD
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
41400000 USD
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
160800000 USD
CY2018 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
416300000 USD
CY2021 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
206900000 USD
CY2019 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
250100000 USD
CY2018 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
339400000 USD
CY2021 swk Income Tax Refund
IncomeTaxRefund
90200000 USD
CY2019 swk Income Tax Refund
IncomeTaxRefund
72500000 USD
CY2018 swk Income Tax Refund
IncomeTaxRefund
43700000 USD
CY2021 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
266100000 USD
CY2019 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
237300000 USD
CY2018 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
214600000 USD
CY2021 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
13000000.0 USD
CY2018 us-gaap Income Tax Effects Allocated Directly To Equity Employee Stock Options
IncomeTaxEffectsAllocatedDirectlyToEquityEmployeeStockOptions
-4100000 USD
CY2019 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
22100000 USD
CY2018 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
24700000 USD
CY2021 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
-41900000 USD
CY2019 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
-53300000 USD
CY2018 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
-33200000 USD
CY2021 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
20300000 USD
CY2019 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
-53100000 USD
CY2018 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
4500000 USD
CY2021 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
-26800000 USD
CY2019 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
10500000 USD
CY2018 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
5100000 USD
CY2021 swk Income Tax Reconciliation Change In Undistributed Earnings
IncomeTaxReconciliationChangeInUndistributedEarnings
118800000 USD
CY2019 swk Income Tax Reconciliation Change In Undistributed Earnings
IncomeTaxReconciliationChangeInUndistributedEarnings
0 USD
CY2018 swk Income Tax Reconciliation Change In Undistributed Earnings
IncomeTaxReconciliationChangeInUndistributedEarnings
0 USD
CY2021 us-gaap Income Tax Effects Allocated Directly To Equity Employee Stock Options
IncomeTaxEffectsAllocatedDirectlyToEquityEmployeeStockOptions
-9800000 USD
CY2019 us-gaap Income Tax Effects Allocated Directly To Equity Employee Stock Options
IncomeTaxEffectsAllocatedDirectlyToEquityEmployeeStockOptions
-24100000 USD
CY2019 us-gaap Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
0 USD
CY2021 us-gaap Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
0 USD
CY2018 us-gaap Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
199600000 USD
CY2021 swk Effective Income Tax Rate Reconciliation Capital Loss
EffectiveIncomeTaxRateReconciliationCapitalLoss
-40400000 USD
CY2019 swk Effective Income Tax Rate Reconciliation Capital Loss
EffectiveIncomeTaxRateReconciliationCapitalLoss
0 USD
CY2018 swk Effective Income Tax Rate Reconciliation Capital Loss
EffectiveIncomeTaxRateReconciliationCapitalLoss
0 USD
CY2021 us-gaap Income Tax Reconciliation Repatriation Of Foreign Earnings
IncomeTaxReconciliationRepatriationOfForeignEarnings
-17700000 USD
CY2019 us-gaap Income Tax Reconciliation Repatriation Of Foreign Earnings
IncomeTaxReconciliationRepatriationOfForeignEarnings
4100000 USD
CY2018 us-gaap Income Tax Reconciliation Repatriation Of Foreign Earnings
IncomeTaxReconciliationRepatriationOfForeignEarnings
2700000 USD
CY2021 swk Effective Income Tax Rate Reconciliation Intra Entity Transfer Of Intellectual Property
EffectiveIncomeTaxRateReconciliationIntraEntityTransferOfIntellectualProperty
-27700000 USD
CY2019 swk Effective Income Tax Rate Reconciliation Intra Entity Transfer Of Intellectual Property
EffectiveIncomeTaxRateReconciliationIntraEntityTransferOfIntellectualProperty
0 USD
CY2018 swk Effective Income Tax Rate Reconciliation Intra Entity Transfer Of Intellectual Property
EffectiveIncomeTaxRateReconciliationIntraEntityTransferOfIntellectualProperty
0 USD
CY2021 us-gaap Income Tax Reconciliation Other Reconciling Items
IncomeTaxReconciliationOtherReconcilingItems
25100000 USD
CY2019 us-gaap Income Tax Reconciliation Other Reconciling Items
IncomeTaxReconciliationOtherReconcilingItems
17300000 USD
CY2018 us-gaap Income Tax Reconciliation Other Reconciling Items
IncomeTaxReconciliationOtherReconcilingItems
2400000 USD
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
41400000 USD
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
160800000 USD
CY2018 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
416300000 USD
CY2019Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
406300000 USD
CY2018Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
406300000 USD
CY2017Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
387800000 USD
CY2021 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
29100000 USD
CY2019 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
48600000 USD
CY2018 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
28300000 USD
CY2021 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
35800000 USD
CY2019 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
78500000 USD
CY2018 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
103000000.0 USD
CY2021 us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
19300000 USD
CY2019 us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
91100000 USD
CY2018 us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
91500000 USD
CY2021 us-gaap Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities
UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
500000 USD
CY2019 us-gaap Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities
UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
300000 USD
CY2018 us-gaap Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities
UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
2500000 USD
CY2021 us-gaap Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
7900000 USD
CY2019 us-gaap Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
35700000 USD
CY2018 us-gaap Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
18800000 USD
CY2021Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
443500000 USD
CY2019Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
406300000 USD
CY2018Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
406300000 USD
CY2021Q1 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
433300000 USD
CY2019Q4 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
398200000 USD
CY2021 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
2300000 USD
CY2019 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
4300000 USD
CY2018 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
15800000 USD
CY2021Q1 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
50100000 USD
CY2019Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
47800000 USD
CY2018Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
52100000 USD
CY2021Q1 us-gaap Lessee Operating Lease Discount Rate
LesseeOperatingLeaseDiscountRate
0.036
CY2021 swk Increaseinleaseliability
Increaseinleaseliability
117500000 USD
CY2021Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
534400000 USD
CY2021Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
522800000 USD
CY2021 us-gaap Operating Lease Cost
OperatingLeaseCost
155400000 USD
CY2019 us-gaap Operating Lease Cost
OperatingLeaseCost
151600000 USD
CY2021 us-gaap Short Term Lease Cost
ShortTermLeaseCost
26300000 USD
CY2019 us-gaap Short Term Lease Cost
ShortTermLeaseCost
26600000 USD
CY2021 us-gaap Variable Lease Cost
VariableLeaseCost
7000000.0 USD
CY2019 us-gaap Variable Lease Cost
VariableLeaseCost
8500000 USD
CY2021 us-gaap Sublease Income
SubleaseIncome
800000 USD
CY2019 us-gaap Sublease Income
SubleaseIncome
2800000 USD
CY2021 us-gaap Lease Cost
LeaseCost
187900000 USD
CY2019 us-gaap Lease Cost
LeaseCost
183900000 USD
CY2021 us-gaap Operating Lease Payments
OperatingLeasePayments
149800000 USD
CY2019 us-gaap Operating Lease Payments
OperatingLeasePayments
154400000 USD
CY2021Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P7Y
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
599300000 USD
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
141400000 USD
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
109600000 USD
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
82300000 USD
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
68300000 USD
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
50100000 USD
CY2021Q1 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
147600000 USD
CY2021 us-gaap Sale Leaseback Transaction Net Proceeds Investing Activities
SaleLeasebackTransactionNetProceedsInvestingActivities
93000000.0 USD
CY2021 us-gaap Sale And Leaseback Transaction Gain Loss Net
SaleAndLeasebackTransactionGainLossNet
69500000 USD
CY2019 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
177600000 USD
CY2021Q1 us-gaap Guarantee Obligations Maximum Exposure
GuaranteeObligationsMaximumExposure
316600000 USD
CY2021Q1 us-gaap Guarantee Obligations Current Carrying Value
GuaranteeObligationsCurrentCarryingValue
7900000 USD
CY2019Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
100100000 USD
CY2018Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
102100000 USD
CY2017Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
108500000 USD
CY2021 us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
128500000 USD
CY2019 us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
128100000 USD
CY2018 us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
110400000 USD
CY2021 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
114800000 USD
CY2019 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
130100000 USD
CY2018 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
116800000 USD
CY2021Q1 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
113800000 USD
CY2019Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
100100000 USD
CY2018Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
102100000 USD
CY2021 us-gaap Loss Contingency Disclosures
LossContingencyDisclosures
CONTINGENCIES<div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is involved in various legal proceedings relating to environmental issues, employment, product liability, workers’ compensation claims and other matters. The Company periodically reviews the status of these proceedings with both inside and outside counsel, as well as an actuary for risk insurance. Management believes that the ultimate disposition of these matters will not have a material adverse effect on operations or financial condition taken as a whole.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 25, 2019, IPS Worldwide, LLC ("IPS"), a third-party provider of freight payment processing services for the Company, filed for Chapter 11 bankruptcy protection and listed the Company as an unsecured creditor. As of December 29, 2018, there were outstanding obligations of approximately $50.8 million owed to certain of the Company's freight carriers. Such amounts had previously been remitted to IPS through a third-party financing program for ultimate payment to these freight carriers. However, due to nonperformance of IPS with respect to processing these payments and the Company's obligation to its freight carriers, an incremental $50.8 million charge was recorded in the fourth quarter of 2018. This charge did not include any amounts that the Company will attempt to recover from insurance and/or through the bankruptcy proceedings, which could ultimately reduce the loss exposure recorded.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the normal course of business, the Company is a party to administrative proceedings and litigation, before federal and state regulatory agencies, relating to environmental remediation with respect to claims involving the discharge of hazardous substances into the environment, generally at current and former manufacturing facilities. In addition, some of these claims assert that the Company is responsible for damages and liability, for remedial investigation and clean-up costs, with respect to sites that have never been owned or operated by the Company, but the Company has been identified as a potentially responsible party ("PRP"). </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the 2010 merger with Black &amp; Decker, the Company assumed certain commitments and contingent liabilities. Black &amp; Decker is a party to litigation and administrative proceedings with respect to claims involving the discharge of hazardous substances into the environment at current and former manufacturing facilities and has also been named as a PRP in certain administrative proceedings.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company, along with many other companies, has been named as a PRP in numerous administrative proceedings for the remediation of various waste sites, including 28 active Superfund sites. Current laws potentially impose joint and several liabilities upon each PRP. In assessing its potential liability at these sites, the Company has considered the following: whether responsibility is being disputed, the terms of existing agreements, experience at similar sites, and the Company’s volumetric contribution at these sites.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s policy is to accrue environmental investigatory and remediation costs for identified sites when it is probable that a liability has been incurred and the amount of loss can be reasonably estimated. If no amount in the range of probable loss is considered most likely, the minimum loss in the range is accrued. The amount of liability recorded is based on an evaluation of currently available facts with respect to each individual site and includes such factors as existing technology, presently enacted laws and regulations, and prior experience in remediation of contaminated sites. The liabilities recorded do not take into account any claims for recoveries from insurance or third parties. As assessments and remediation progress at individual sites, the amounts recorded are reviewed periodically and adjusted to reflect additional technical and legal information that becomes available. As of January 2, 2021 and December 28, 2019, the Company had reserves of $174.2 million and $213.8 million, respectively, for remediation activities associated with Company-owned properties, as well as for Superfund sites, for losses that are probable and estimable. Of the 2020 amount, $46.7 million is classified as current and $127.5 million as long-term which is expected to be paid over the estimated remediation period. As of January 2, 2021, the range of environmental remediation costs that is reasonably possible is $102.9 million to $245.3 million which is subject to change in the near term. The Company may be liable for environmental remediation of sites it no longer owns. Liabilities have been recorded on those sites in accordance with the Company's policy.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of January 2, 2021, the Company has recorded $15.9 million in other assets related to funding received by the Environmental Protection Agency (“EPA”) and placed in a trust in accordance with the final settlement with the EPA, embodied in a Consent Decree approved by the United States District Court for the Central District of California on July 3, 2013. Per the Consent Decree, Emhart Industries, Inc. (a dissolved and liquidated former indirectly wholly-owned subsidiary of The Black &amp; Decker Corporation) (“Emhart”) has agreed to be responsible for an interim remedy at a site located in Rialto, California and formerly operated by West Coast Loading Corporation (“WCLC”), a defunct company for which Emhart was alleged to be liable as a successor. The remedy will be funded by (i) the amounts received from the EPA as gathered from multiple parties, and, to the extent necessary, (ii) Emhart's affiliate. The interim remedy requires the construction of a water treatment facility and the filtering of ground water at or around the site for a period of approximately 30 years or more. As of January 2, 2021, the Company's net cash obligation associated with remediation activities, including WCLC assets, is $158.3 million. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The EPA also asserted claims in federal court in Rhode Island against Black &amp; Decker and Emhart related to environmental contamination found at the Centredale Manor Restoration Project Superfund Site ("Centredale"), located in North Providence, Rhode Island. The EPA discovered a variety of contaminants at the site, including but not limited to, dioxins, polychlorinated biphenyls, and pesticides. The EPA alleged that Black &amp; Decker and Emhart are liable for site clean-up costs under the Comprehensive Environmental Response, Compensation, and Liability Act ("CERCLA") as successors to the liability of Metro-Atlantic, Inc., a former operator at the site, and demanded reimbursement of the EPA’s costs related to this site. Black &amp; Decker and Emhart contested the EPA's allegation that they are responsible for the contamination, and asserted contribution claims, counterclaims and cross-claims against a number of other PRPs, including the federal government as well as insurance carriers. The EPA released its Record of Decision ("ROD") in September 2012, which identified and described the EPA's selected remedial alternative for the site. Black &amp; Decker and Emhart contested the EPA's selection of the remedial alternative set forth in the ROD on the grounds that the EPA's actions were arbitrary and capricious and otherwise not in accordance with law, and proposed other equally-protective, more cost-effective alternatives. On June 10, 2014, the EPA issued an Administrative Order under Sec. 106 of CERCLA, instructing Black &amp; Decker and Emhart to perform the remediation of Centredale pursuant to the ROD. Black &amp; Decker and Emhart disputed the factual, legal and scientific bases cited by the EPA for such an administrative order and provided the EPA with numerous good-faith bases for their declination to comply with the administrative order. Black &amp; Decker and Emhart then vigorously litigated the issue of their liability for environmental conditions at the Centredale site, including completing trial on Phase 1 of the proceedings in late July 2015 and completing trial on Phase 2 of the proceedings in April 2017. Following the Phase I trial, the Court found that dioxin contamination at the Centredale site was not "divisible" and that Black &amp; Decker and Emhart were jointly and severally liable for dioxin contamination at the site. Following the Phase 2 trial, the Court found that certain components of the EPA's selected remedy were arbitrary and capricious, and remanded the matter to the EPA while retaining jurisdiction over the ongoing remedy selection and implementation process. The Court also held in Phase 2 that Black &amp; Decker and Emhart had sufficient cause for their declination to comply with the EPA's June 10, 2014 administrative order and that no associated civil penalties or fines were warranted. The United States filed a Motion for Reconsideration concerning the Court's Phase 2 rulings and appealed the ruling to the United States Court of Appeals for the First Circuit. Black &amp; Decker and Emhart's Motion to Dismiss the Appeal was denied without prejudice for consideration with the merits. On July 9, 2018, a Consent Decree was lodged with the United States District Court documenting the terms of a settlement between the Company and the United States for reimbursement of EPA's past costs and remediation of environmental contamination found at the Centredale site. The terms of the Consent Decree were subject to public comment and Court approval. After a full hearing on March 19, 2019, the Court approved and entered the Consent Decree on April 8, 2019. The settlement resolves outstanding issues relating to Phase 1 and 2 of the litigation with the United States. The Company is complying with the terms of the settlement while several PRPs at the site have appealed the District Court's entry of the Consent Decree to the United States Court of Appeals for the First Circuit. Phase 3 of the litigation, is addressing the potential allocation of liability to other PRPs who may have contributed to contamination of the Centredale site with dioxins, polychlorinated biphenyls and other contaminants of concern. Based on the Company's estimated remediation and response cost obligations arising out of the settlement reached with the United States (including the EPA’s past costs as well as costs of additional investigation, remediation, and related costs such as EPA’s oversight costs), the Company has increased its reserve for this site. Accordingly, in 2018, a $77.7 million increase was recorded in Other, net in the Consolidated Statements of Operations. As of January 2, 2021, the Company has a remaining reserve of $74.2 million for this site.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company and approximately 47 other companies comprise the Lower Passaic Cooperating Parties Group (the “CPG”). The CPG members and other companies are parties to a May 2007 Administrative Settlement Agreement and Order on Consent (“AOC”) with the EPA to perform a remedial investigation/feasibility study (“RI/FS”) of the lower seventeen miles of the Lower Passaic River in New Jersey (the “River”). The Company’s potential liability stems from former operations in Newark, New Jersey. As an interim step related to the 2007 AOC, on June 18, 2012,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the CPG members voluntarily entered into an AOC with the EPA for remediation actions focused solely at mile 10.9 of the River. The Company’s estimated costs related to the RI/FS and focused remediation action at mile 10.9, based on an interim allocation, are included in its environmental reserves. On April 11, 2014, the EPA issued a Focused Feasibility Study (“FFS”) and proposed plan which addressed various early action remediation alternatives for the lower 8.3 miles of the River. The EPA received public comment on the FFS and proposed plan (including comments from the CPG and other entities asserting that the FFS and proposed plan do not comply with CERCLA) which public comment period ended on August 20, 2014. The CPG submitted to the EPA a draft RI report in February 2015 and draft FS report in April 2015 for the entire lower seventeen miles of the River. On March 4, 2016, the EPA issued a Record of Decision ("ROD") selecting the remedy for the lower 8.3 miles of the River. The cleanup plan adopted by the EPA is now considered a final action for the lower 8.3 miles of the River and will include the removal of 3.5 million cubic yards of sediment, placement of a cap over the entire lower 8.3 miles of the River, and, according to the EPA, will cost approximately $1.4 billion and take 6 years to implement after the remedial design is completed. The Company and 105 other parties received a letter dated March 31, 2016 from the EPA notifying such parties of potential liability for the costs of the cleanup of the lower 8.3 miles of the River and a letter dated March 30, 2017 stating that the EPA had offered 20 of the parties (not including the Company) an early cash out settlement. In a letter dated May 17, 2017, the EPA stated that these 20 parties did not discharge any of the eight hazardous substances identified as the contaminants of concern in the lower 8.3 mile ROD. In the March 30, </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2017 letter, the EPA stated that other parties who did not discharge dioxins, furans or polychlorinated biphenyls (which are considered the contaminants of concern posing the greatest risk to human health or the environment) may also be eligible for cash out settlement, but expects those parties' allocation to be determined through a complex settlement analysis using a third-party allocator. The EPA subsequently clarified this statement to say that such parties would be eligible to be "funding parties" for the lower 8.3 mile remedial action with each party's share of the costs determined by the EPA based on the allocation process and the remaining parties would be "work parties" for the remedial action. The Company is participating in the allocation process. The allocator selected by the EPA issued a confidential financial report on December 28, 2020, which is under review by the EPA. The Company asserts that it did not discharge dioxins, furans or polychlorinated biphenyls and should be eligible to be a "funding party" for the lower 8.3 mile remedial action. On September 30, 2016, Occidental Chemical Corporation ("OCC") entered into an agreement with the EPA to perform the remedial design for the cleanup plan for the lower 8.3 miles of the River. The remedial design is expected to be substantially completed in May 2021. On June 30, 2018, OCC filed a complaint in the United States District Court for the District of New Jersey against over 100 companies, including the Company, seeking CERCLA cost recovery or contribution for past costs relating to various investigations and cleanups OCC has conducted or is conducting in connection with the River. According to the complaint, OCC has incurred or is incurring costs which include the estimated cost ($165 million) to complete the remedial design for the cleanup plan for the lower 8.3 miles of the River. OCC also seeks a declaratory judgment to hold the defendants liable for their proper shares of future response costs for OCC's ongoing activities in connection with the River. The Company and other defendants have answered the complaint and currently are engaged in discovery with OCC. On October 10, 2018, the EPA issued a letter directing the CPG to prepare a streamlined feasibility study for the upper 9 miles of the River based on an iterative approach using adaptive management strategies. The CPG submitted a revi</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">sed draft Interim </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Remedy Feasibility Study to the EPA on December 4, 2020, which identifies various targeted dredge and cap alternatives with costs that range from $420 million to $468 million (net present value). The EPA approved the Interim Remedy Feasibility Study on December 11, 2020. The EPA announced that it intends to issue the Interim Remedy ROD in the Winter of 2020/2021. At this time, the Company cannot reasonably estimate its liability related to the litigation and remediation efforts, excluding the RI/FS and remediation actions at mile 10.9, as the RI/FS is ongoing, the ultimate remedial approach and associated cost for the upper portion of the River has not yet been determined, and the parties that will participate in funding the remediation and their respective allocations are not yet known. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Per the terms of a Final Order and Judgment approved by the United States District Court for the Middle District of Florida on January 22, 1991, Emhart is responsible for a percentage of remedial costs arising out of the Kerr McGee Chemical Corporation Superfund Site located in Jacksonville, Florida. On March 15, 2017, the Company received formal notification from the EPA that the EPA had issued a ROD selecting the preferred alternative identified in the Proposed Cleanup Plan. As of January 2, 2021, the Company has reserved $24.7 million for this site.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The environmental liability for certain sites that have cash payments beyond the current year that are fixed or reliably determinable have been discounted using a rate of 0.1% to 1.8%, depending on the expected timing of disbursements. The discounted and undiscounted amount of the liability relative to these sites is $42.6 million and $45.9 million, respectively. The payments relative to these sites are expected to be $1.4 million in 2021, $2.9 million in 2022, $2.9 million in 2023, $3.1 million in 2024, $2.8 million in 2025, and $32.8 million thereafter.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amount recorded for identified contingent liabilities is based on estimates. Amounts recorded are reviewed periodically and adjusted to reflect additional technical and legal information that becomes available. Actual costs to be incurred in future periods may vary from the estimates, given the inherent uncertainties in evaluating certain exposures. Subject to the imprecision in estimating future contingent liability costs, the Company does not expect that any sum it may have to pay in connection with these matters in excess of the amounts recorded will have a materially adverse effect on its financial position, results of operations or liquidity.</span></div>
CY2021Q1 swk Superfund Sites
SuperfundSites
28 site
CY2021Q1 us-gaap Other Assets Miscellaneous
OtherAssetsMiscellaneous
15900000 USD
CY2021 swk Environmentalremediation.Periodconstructionoftreatmentfacilitytobemaintained
Environmentalremediation.Periodconstructionoftreatmentfacilitytobemaintained
P30Y
CY2007Q2 swk Environmental Remedial Investigation Feasibility Study Number Of Miles
EnvironmentalRemedialInvestigationFeasibilityStudyNumberOfMiles
17 mi
CY2014Q2 swk Environmental Remedial Investigation Feasibility Study Number Of Miles
EnvironmentalRemedialInvestigationFeasibilityStudyNumberOfMiles
8.3 mi
CY2015Q2 swk Environmental Remedial Investigation Feasibility Study Number Of Miles
EnvironmentalRemedialInvestigationFeasibilityStudyNumberOfMiles
17 mi
CY2016Q1 swk Environmental Remedial Investigation Feasibility Study Number Of Miles
EnvironmentalRemedialInvestigationFeasibilityStudyNumberOfMiles
8.3 mi
CY2016Q1 swk Environmental Remedial Investigation Feasibility Study Number Of Miles
EnvironmentalRemedialInvestigationFeasibilityStudyNumberOfMiles
8.3 mi
CY2016Q1 swk Environmental Remediation Cubic Yards Of Sediment
EnvironmentalRemediationCubicYardsOfSediment
3500000 ft3
CY2016Q1 swk Environmental Remedial Investigation Feasibility Study Number Of Miles
EnvironmentalRemedialInvestigationFeasibilityStudyNumberOfMiles
8.3 mi
CY2016Q1 us-gaap Environmental Exit Costs Anticipated Cost
EnvironmentalExitCostsAnticipatedCost
1400000000 USD
CY2016Q1 swk Environmental Remediation Estimated Remedial Design Implementation Period
EnvironmentalRemediationEstimatedRemedialDesignImplementationPeriod
P6Y
CY2016Q1 swk Environmental Remediation Number Of Other Parties Notified
EnvironmentalRemediationNumberOfOtherPartiesNotified
105 age
CY2016Q1 swk Environmental Remedial Investigation Feasibility Study Number Of Miles
EnvironmentalRemedialInvestigationFeasibilityStudyNumberOfMiles
8.3 mi
CY2017Q1 swk Number Of Other Companies Offered Cash Out Settlements
NumberOfOtherCompaniesOfferedCashOutSettlements
20 Company
CY2017Q1 swk Number Of Other Companies Offered Cash Out Settlements
NumberOfOtherCompaniesOfferedCashOutSettlements
20 Company
CY2017Q2 swk Environmental Remediation Number Of Hazardous Substances
EnvironmentalRemediationNumberOfHazardousSubstances
8 Hazardous_Substance
CY2016Q1 swk Environmental Remedial Investigation Feasibility Study Number Of Miles
EnvironmentalRemedialInvestigationFeasibilityStudyNumberOfMiles
8.3 mi
CY2016Q1 swk Environmental Remedial Investigation Feasibility Study Number Of Miles
EnvironmentalRemedialInvestigationFeasibilityStudyNumberOfMiles
8.3 mi
CY2016Q1 swk Environmental Remedial Investigation Feasibility Study Number Of Miles
EnvironmentalRemedialInvestigationFeasibilityStudyNumberOfMiles
8.3 mi
CY2016Q1 swk Environmental Remedial Investigation Feasibility Study Number Of Miles
EnvironmentalRemedialInvestigationFeasibilityStudyNumberOfMiles
8.3 mi
CY2018Q2 us-gaap Loss Contingency Number Of Defendants
LossContingencyNumberOfDefendants
100 Company
CY2018Q2 swk Environmental Remediation Estimated Remedial Design Cleanup Cost
EnvironmentalRemediationEstimatedRemedialDesignCleanupCost
165000000 USD
CY2016Q1 swk Environmental Remedial Investigation Feasibility Study Number Of Miles
EnvironmentalRemedialInvestigationFeasibilityStudyNumberOfMiles
8.3 mi
CY2018Q4 swk Environmental Remedial Investigation Feasibility Study Number Of Miles
EnvironmentalRemedialInvestigationFeasibilityStudyNumberOfMiles
9 mi
CY2021Q1 us-gaap Accrual For Environmental Loss Contingencies Undiscounted Due Within One Year
AccrualForEnvironmentalLossContingenciesUndiscountedDueWithinOneYear
1400000 USD
CY2021Q1 us-gaap Accrual For Environmental Loss Contingencies Undiscounted Due In Second Year
AccrualForEnvironmentalLossContingenciesUndiscountedDueInSecondYear
2900000 USD
CY2021Q1 us-gaap Accrual For Environmental Loss Contingencies Undiscounted Due In Third Year
AccrualForEnvironmentalLossContingenciesUndiscountedDueInThirdYear
2900000 USD
CY2021Q1 us-gaap Accrual For Environmental Loss Contingencies Undiscounted Due In Fourth Year
AccrualForEnvironmentalLossContingenciesUndiscountedDueInFourthYear
3100000 USD
CY2021Q1 us-gaap Accrual For Environmental Loss Contingencies Undiscounted Due In Fifth Year
AccrualForEnvironmentalLossContingenciesUndiscountedDueInFifthYear
2800000 USD
CY2021Q1 us-gaap Accrual For Environmental Loss Contingencies Undiscounted Due After Fifth Year
AccrualForEnvironmentalLossContingenciesUndiscountedDueAfterFifthYear
32800000 USD
CY2020Q1 us-gaap Revenues
Revenues
3129400000 USD
CY2020Q2 us-gaap Revenues
Revenues
3147400000 USD
CY2020Q3 us-gaap Revenues
Revenues
3850200000 USD
us-gaap Revenues
Revenues
4407600000 USD
CY2021 us-gaap Revenues
Revenues
14534600000 USD
CY2020Q1 us-gaap Gross Profit
GrossProfit
1023100000 USD
CY2020Q2 us-gaap Gross Profit
GrossProfit
1012700000 USD
CY2020Q3 us-gaap Gross Profit
GrossProfit
1376300000 USD
us-gaap Gross Profit
GrossProfit
1555800000 USD
CY2021 us-gaap Gross Profit
GrossProfit
4967900000 USD
CY2020Q1 swk Selling Generaland Administrative Expense Totalincluding Allowancefor Doubtful Accounts
SellingGeneralandAdministrativeExpenseTotalincludingAllowanceforDoubtfulAccounts
748500000 USD
CY2020Q2 swk Selling Generaland Administrative Expense Totalincluding Allowancefor Doubtful Accounts
SellingGeneralandAdministrativeExpenseTotalincludingAllowanceforDoubtfulAccounts
732000000.0 USD
CY2020Q3 swk Selling Generaland Administrative Expense Totalincluding Allowancefor Doubtful Accounts
SellingGeneralandAdministrativeExpenseTotalincludingAllowanceforDoubtfulAccounts
738900000 USD
swk Selling Generaland Administrative Expense Totalincluding Allowancefor Doubtful Accounts
SellingGeneralandAdministrativeExpenseTotalincludingAllowanceforDoubtfulAccounts
870200000 USD
CY2021 swk Selling Generaland Administrative Expense Totalincluding Allowancefor Doubtful Accounts
SellingGeneralandAdministrativeExpenseTotalincludingAllowanceforDoubtfulAccounts
3089600000 USD
CY2020Q1 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
133100000 USD
CY2020Q2 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
238700000 USD
CY2020Q3 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
395200000 USD
us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
467700000 USD
CY2021 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
1234700000 USD
CY2020Q1 us-gaap Income Loss From Continuing Operations Attributable To Noncontrolling Entity
IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity
-100000 USD
CY2020Q2 us-gaap Income Loss From Continuing Operations Attributable To Noncontrolling Entity
IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity
300000 USD
CY2020Q3 us-gaap Income Loss From Continuing Operations Attributable To Noncontrolling Entity
IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity
300000 USD
us-gaap Income Loss From Continuing Operations Attributable To Noncontrolling Entity
IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity
400000 USD
CY2021 us-gaap Income Loss From Continuing Operations Attributable To Noncontrolling Entity
IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity
900000 USD
CY2020Q1 us-gaap Dividends Preferred Stock
DividendsPreferredStock
0 USD
CY2020Q2 us-gaap Dividends Preferred Stock
DividendsPreferredStock
4700000 USD
CY2020Q3 us-gaap Dividends Preferred Stock
DividendsPreferredStock
9400000 USD
us-gaap Dividends Preferred Stock
DividendsPreferredStock
9300000 USD
CY2021 us-gaap Dividends Preferred Stock
DividendsPreferredStock
23400000 USD
CY2020Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
133200000 USD
CY2020Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
233700000 USD
CY2020Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
385500000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
458000000.0 USD
CY2021 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
1210400000 USD
CY2020Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.89
CY2020Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.52
CY2020Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.47
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.92
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
7.85
CY2020Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.88
CY2020Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.52
CY2020Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.44
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.88
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
7.77
CY2019Q1 us-gaap Revenues
Revenues
3333600000 USD
CY2019Q2 us-gaap Revenues
Revenues
3761300000 USD
CY2019Q3 us-gaap Revenues
Revenues
3633100000 USD
CY2019Q4 us-gaap Revenues
Revenues
3714200000 USD
CY2019 us-gaap Revenues
Revenues
14442200000 USD
CY2019Q1 us-gaap Gross Profit
GrossProfit
1105600000 USD
CY2019Q2 us-gaap Gross Profit
GrossProfit
1299800000 USD
CY2019Q3 us-gaap Gross Profit
GrossProfit
1239500000 USD
CY2019Q4 us-gaap Gross Profit
GrossProfit
1160600000 USD
CY2019 us-gaap Gross Profit
GrossProfit
4805500000 USD
CY2019Q1 swk Selling Generaland Administrative Expense Totalincluding Allowancefor Doubtful Accounts
SellingGeneralandAdministrativeExpenseTotalincludingAllowanceforDoubtfulAccounts
778900000 USD
CY2019Q2 swk Selling Generaland Administrative Expense Totalincluding Allowancefor Doubtful Accounts
SellingGeneralandAdministrativeExpenseTotalincludingAllowanceforDoubtfulAccounts
782300000 USD
CY2019Q3 swk Selling Generaland Administrative Expense Totalincluding Allowancefor Doubtful Accounts
SellingGeneralandAdministrativeExpenseTotalincludingAllowanceforDoubtfulAccounts
756100000 USD
CY2019Q4 swk Selling Generaland Administrative Expense Totalincluding Allowancefor Doubtful Accounts
SellingGeneralandAdministrativeExpenseTotalincludingAllowanceforDoubtfulAccounts
723700000 USD
CY2019 swk Selling Generaland Administrative Expense Totalincluding Allowancefor Doubtful Accounts
SellingGeneralandAdministrativeExpenseTotalincludingAllowanceforDoubtfulAccounts
3041000000.0 USD
CY2019Q1 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
170400000 USD
CY2019Q2 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
357400000 USD
CY2019Q3 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
231100000 USD
CY2019Q4 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
199100000 USD
CY2019 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
958000000.0 USD
CY2019Q1 us-gaap Income Loss From Continuing Operations Attributable To Noncontrolling Entity
IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity
500000 USD
CY2019Q2 us-gaap Income Loss From Continuing Operations Attributable To Noncontrolling Entity
IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity
1100000 USD
CY2019Q3 us-gaap Income Loss From Continuing Operations Attributable To Noncontrolling Entity
IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity
600000 USD
CY2019Q4 us-gaap Income Loss From Continuing Operations Attributable To Noncontrolling Entity
IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity
0 USD
CY2019 us-gaap Income Loss From Continuing Operations Attributable To Noncontrolling Entity
IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity
2200000 USD
CY2019Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
169900000 USD
CY2019Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
356300000 USD
CY2019Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
230500000 USD
CY2019Q4 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
199100000 USD
CY2019 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
955800000 USD
CY2019Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.15
CY2019Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.41
CY2019Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.55
CY2019Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.34
CY2019 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
6.44
CY2019Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.13
CY2019Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.37
CY2019Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.53
CY2019Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.32
CY2019 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
6.35
CY2021 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
400000000 USD
CY2021Q1 swk Tax Cutsand Jobs Actof2017
TaxCutsandJobsActof2017
211000000 USD
CY2021 swk Business Combination Acquisition Related Costs Netof Tax
BusinessCombinationAcquisitionRelatedCostsNetofTax
10000000 USD
CY2020Q1 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
62000000 USD
CY2020Q1 swk Business Combination Acquisition Related Costs Netof Tax
BusinessCombinationAcquisitionRelatedCostsNetofTax
50000000 USD
CY2020Q1 swk Business Combination Acquisition Related Costs Diluted Earnings Per Share Impact
BusinessCombinationAcquisitionRelatedCostsDilutedEarningsPerShareImpact
-0.32
CY2020Q2 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
169000000 USD
CY2020Q2 swk Business Combination Acquisition Related Costs Netof Tax
BusinessCombinationAcquisitionRelatedCostsNetofTax
13000000 USD
CY2020Q2 swk Business Combination Acquisition Related Costs Diluted Earnings Per Share Impact
BusinessCombinationAcquisitionRelatedCostsDilutedEarningsPerShareImpact
-0.08
CY2020Q3 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
89000000 USD
CY2020Q3 swk Business Combination Acquisition Related Costs Netof Tax
BusinessCombinationAcquisitionRelatedCostsNetofTax
71000000 USD
CY2020Q3 swk Business Combination Acquisition Related Costs Diluted Earnings Per Share Impact
BusinessCombinationAcquisitionRelatedCostsDilutedEarningsPerShareImpact
-0.45
us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
80000000 USD
swk Business Combination Acquisition Related Costs Netof Tax
BusinessCombinationAcquisitionRelatedCostsNetofTax
65000000 USD
swk Business Combination Acquisition Related Costs Diluted Earnings Per Share Impact
BusinessCombinationAcquisitionRelatedCostsDilutedEarningsPerShareImpact
-0.41
CY2019 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
363000000 USD
CY2019Q4 swk Tax Cutsand Jobs Actof2017
TaxCutsandJobsActof2017
78000000 USD
CY2019 swk Business Combination Acquisition Related Costs Netof Tax
BusinessCombinationAcquisitionRelatedCostsNetofTax
24000000 USD
CY2019Q1 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
52000000 USD
CY2019Q1 swk Business Combination Acquisition Related Costs Netof Tax
BusinessCombinationAcquisitionRelatedCostsNetofTax
43000000 USD
CY2019Q1 swk Business Combination Acquisition Related Costs Diluted Earnings Per Share Impact
BusinessCombinationAcquisitionRelatedCostsDilutedEarningsPerShareImpact
-0.29
CY2019Q2 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
33000000 USD
CY2019Q2 swk Business Combination Acquisition Related Costs Netof Tax
BusinessCombinationAcquisitionRelatedCostsNetofTax
44000000 USD
CY2019Q2 swk Business Combination Acquisition Related Costs Diluted Earnings Per Share Impact
BusinessCombinationAcquisitionRelatedCostsDilutedEarningsPerShareImpact
-0.29
CY2019Q3 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
114000000 USD
CY2019Q3 swk Business Combination Acquisition Related Costs Netof Tax
BusinessCombinationAcquisitionRelatedCostsNetofTax
91000000 USD
CY2019Q3 swk Business Combination Acquisition Related Costs Diluted Earnings Per Share Impact
BusinessCombinationAcquisitionRelatedCostsDilutedEarningsPerShareImpact
-0.60
CY2019Q4 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
164000000 USD
CY2019Q4 swk Business Combination Acquisition Related Costs Netof Tax
BusinessCombinationAcquisitionRelatedCostsNetofTax
131000000 USD
CY2019Q4 swk Business Combination Acquisition Related Costs Diluted Earnings Per Share Impact
BusinessCombinationAcquisitionRelatedCostsDilutedEarningsPerShareImpact
-0.86

Files In Submission

Name View Source Status
0000093556-21-000008-index-headers.html Edgar Link pending
0000093556-21-000008-index.html Edgar Link pending
0000093556-21-000008.txt Edgar Link pending
0000093556-21-000008-xbrl.zip Edgar Link pending
a1017thesbdrsuplanfornon-e.htm Edgar Link pending
a1029formofcicagreement.htm Edgar Link pending
a106formofcicforwyattandra.htm Edgar Link pending
a107deferredcompensationpl.htm Edgar Link pending
ex-10kx311a10k2020.htm Edgar Link pending
ex-10kx311b10k2020.htm Edgar Link pending
ex-10kx32110k2020.htm Edgar Link pending
ex-10kx32210k2020.htm Edgar Link pending
ex1028robinsongraham.htm Edgar Link pending
ex21-subsidiariesofstanley.htm Edgar Link pending
ex23-consent10k2020.htm Edgar Link pending
ex24-powerofattorney10k2020.htm Edgar Link pending
ex411-descriptionofsecurit.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
imagea051.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R100.htm Edgar Link pending
R101.htm Edgar Link pending
R102.htm Edgar Link pending
R103.htm Edgar Link pending
R104.htm Edgar Link pending
R105.htm Edgar Link pending
R106.htm Edgar Link pending
R107.htm Edgar Link pending
R108.htm Edgar Link pending
R109.htm Edgar Link pending
R11.htm Edgar Link pending
R110.htm Edgar Link pending
R111.htm Edgar Link pending
R112.htm Edgar Link pending
R113.htm Edgar Link pending
R114.htm Edgar Link pending
R115.htm Edgar Link pending
R116.htm Edgar Link pending
R117.htm Edgar Link pending
R118.htm Edgar Link pending
R119.htm Edgar Link pending
R12.htm Edgar Link pending
R120.htm Edgar Link pending
R121.htm Edgar Link pending
R122.htm Edgar Link pending
R123.htm Edgar Link pending
R124.htm Edgar Link pending
R125.htm Edgar Link pending
R126.htm Edgar Link pending
R127.htm Edgar Link pending
R128.htm Edgar Link pending
R129.htm Edgar Link pending
R13.htm Edgar Link pending
R130.htm Edgar Link pending
R131.htm Edgar Link pending
R132.htm Edgar Link pending
R133.htm Edgar Link pending
R134.htm Edgar Link pending
R135.htm Edgar Link pending
R136.htm Edgar Link pending
R137.htm Edgar Link pending
R138.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R86.htm Edgar Link pending
R87.htm Edgar Link pending
R88.htm Edgar Link pending
R89.htm Edgar Link pending
R9.htm Edgar Link pending
R90.htm Edgar Link pending
R91.htm Edgar Link pending
R92.htm Edgar Link pending
R93.htm Edgar Link pending
R94.htm Edgar Link pending
R95.htm Edgar Link pending
R96.htm Edgar Link pending
R97.htm Edgar Link pending
R98.htm Edgar Link pending
R99.htm Edgar Link pending
R9999.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
swk-20210102.htm Edgar Link pending
swk-20210102.xsd Edgar Link pending
swk-20210102_cal.xml Edgar Link unprocessable
swk-20210102_def.xml Edgar Link unprocessable
swk-20210102_g1.jpg Edgar Link pending
swk-20210102_htm.xml Edgar Link completed
swk-20210102_lab.xml Edgar Link unprocessable
swk-20210102_pre.xml Edgar Link unprocessable